Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,16213,244,1.18 [0.56-2.48],0.6570452876007817
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,15741,240,0.91 [0.71-1.16],0.4408891603468775
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,18561,288,0.89 [0.73-1.08],0.2266463528781456
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,15662,238,0.96 [0.67-1.37],0.8221074509074151
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,18444,288,0.97 [0.80-1.17],0.7466843267721308
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,18561,288,1.06 [0.91-1.23],0.4822243062471872
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,16208,243,1.04 [0.96-1.13],0.3318909837902698
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,15662,238,1.00 [0.82-1.21],0.970116523426448
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",18230,284,1.03 [0.90-1.18],0.6560850306347715
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",15910,241,0.94 [0.77-1.14],0.5083527559865411
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",16189,244,0.94 [0.81-1.08],0.3548645069769622
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,18451,285,1.35 [0.92-1.99],0.1308025907948023
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,16208,243,1.10 [0.71-1.70],0.677052563905343
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,18323,284,1.10 [0.91-1.33],0.3410027834179637
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,15830,235,1.01 [0.70-1.46],0.939773563503241
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,16136,244,0.97 [0.87-1.08],0.6173522550197429
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,18653,291,1.07 [0.87-1.31],0.5045689074485673
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,15703,236,0.82 [0.61-1.10],0.1811089113759205
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,18734,295,1.26 [0.92-1.72],0.149624903469962
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,18806,293,0.95 [0.82-1.10],0.4749118495558186
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,16130,242,0.90 [0.65-1.23],0.4928505931609505
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,15703,236,0.94 [0.84-1.06],0.3296881671775056
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,15662,238,0.85 [0.57-1.25],0.4097209468828906
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",18323,284,1.00 [0.78-1.28],0.9901709765989494
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,15662,238,1.20 [0.99-1.45],0.0567853317494568
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,18340,284,0.91 [0.65-1.29],0.60180186911397
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,18470,291,1.09 [0.72-1.63],0.6869688586358443
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,18653,291,1.04 [0.87-1.23],0.6745262084046072
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,15662,238,1.06 [0.85-1.33],0.604757287874744
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,15782,235,0.96 [0.79-1.16],0.6584175706636144
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,18876,294,0.78 [0.58-1.06],0.1079639113810187
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,18570,289,1.05 [0.82-1.33],0.7159209508318031
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,15703,236,0.92 [0.62-1.37],0.6847750705652527
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,18323,284,1.02 [0.73-1.44],0.8912532597699995
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,18504,291,0.99 [0.74-1.32],0.9400995397449076
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,18876,294,1.09 [0.81-1.46],0.5880540290784636
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,18790,294,1.23 [0.86-1.77],0.2559050403357034
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,16136,244,1.27 [0.84-1.90],0.2519380444853064
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,15703,236,1.24 [0.86-1.80],0.2484084116430865
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,18887,296,1.41 [0.91-2.18],0.1259204424905544
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,18561,288,0.91 [0.71-1.18],0.4814490299895413
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,18323,284,1.14 [0.87-1.50],0.335813968879139
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,15703,236,1.11 [0.78-1.57],0.566866414804364
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,18698,293,0.93 [0.74-1.17],0.5311318958374396
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,16200,246,1.17 [0.82-1.67],0.3831663951443255
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,15741,240,0.95 [0.57-1.58],0.8350066009925619
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,16189,244,0.74 [0.54-1.01],0.0587870911817248
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,18230,284,0.97 [0.70-1.35],0.8736195918467877
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,15830,235,0.86 [0.72-1.03],0.0992677787408506
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,18470,291,1.03 [0.75-1.40],0.8648661824584765
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,15830,235,1.06 [0.77-1.45],0.7264608457398493
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,16136,244,1.06 [0.85-1.34],0.5892840921537219
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,18710,288,1.15 [0.80-1.66],0.4490917499740484
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,18797,296,1.14 [0.82-1.59],0.4231483727429325
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,16189,244,1.10 [0.69-1.76],0.6780569772550424
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,18561,288,1.11 [0.99-1.23],0.0724727477969598
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,18653,291,0.93 [0.63-1.37],0.7062176794881485
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,15700,238,0.98 [0.82-1.18],0.8548667635602536
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,15830,235,0.95 [0.80-1.13],0.566362536097855
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,18323,284,1.08 [0.95-1.24],0.2247581911426221
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,16213,244,0.99 [0.83-1.18],0.9257686879535458
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,18830,294,1.12 [0.74-1.69],0.5870944047630411
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,15662,238,1.08 [0.91-1.27],0.3651650160906252
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,15830,235,1.06 [0.91-1.23],0.4665847487796375
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AFM,Afamin,16213,244,1.15 [0.63-2.09],0.6409047284985243
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,18437,291,0.90 [0.77-1.07],0.2268830860890608
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,15700,238,0.92 [0.81-1.05],0.2303362227247098
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,18589,287,1.04 [0.80-1.34],0.7780789232602334
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,18125,287,1.15 [1.04-1.28],0.0094609911419382
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,18203,283,0.93 [0.77-1.11],0.4146940749191542
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,18710,288,1.15 [0.85-1.56],0.356815399366437
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,18876,294,0.96 [0.78-1.17],0.6599294876821755
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,16208,243,0.87 [0.48-1.60],0.6599443424941802
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,18653,291,0.99 [0.86-1.14],0.9002976930874234
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,18653,291,0.97 [0.83-1.13],0.6563806814552955
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,15741,240,0.99 [0.66-1.49],0.9764235918829922
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,15741,240,0.97 [0.64-1.45],0.8762539499000329
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,16130,242,1.05 [0.88-1.25],0.6138055876038437
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,16208,243,1.61 [1.03-2.51],0.0361046138254367
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,18616,292,0.88 [0.78-1.00],0.0554624202285634
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",15777,238,0.95 [0.81-1.10],0.4904759670384719
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,18230,284,0.90 [0.73-1.10],0.2888913504299755
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,15741,240,0.90 [0.70-1.15],0.3852877404211526
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",18536,286,1.01 [0.91-1.11],0.8634042291966841
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,18653,291,0.90 [0.76-1.07],0.2249668237480191
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",16161,245,1.02 [0.91-1.14],0.744286971339629
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,15830,235,0.66 [0.35-1.26],0.2069093012572622
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,18230,284,0.96 [0.83-1.12],0.6214843937053645
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,15777,238,0.99 [0.81-1.21],0.9352252812655304
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,18323,284,1.05 [0.85-1.29],0.6670644817445861
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,15703,236,1.04 [0.86-1.25],0.6860374291759963
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,18258,289,0.97 [0.83-1.14],0.745906660893258
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,16168,245,0.99 [0.90-1.10],0.9174485616394236
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,18144,284,1.05 [0.88-1.27],0.5736317495012304
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,18887,296,1.24 [0.73-2.11],0.4187110073778454
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,18654,292,0.84 [0.68-1.02],0.084236076255387
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",16130,242,1.07 [0.85-1.34],0.5878359294349816
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",18615,290,1.00 [0.86-1.16],0.9608817354155068
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",16168,245,0.98 [0.75-1.28],0.906035441807659
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,15910,241,0.85 [0.62-1.16],0.2995115328231449
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,15703,236,1.09 [0.98-1.20],0.1036791946445293
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",18561,288,1.07 [0.97-1.18],0.1718103301412832
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,18340,284,0.99 [0.67-1.48],0.9701427484964036
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,18804,294,1.43 [0.86-2.37],0.1703262383151406
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,16200,246,1.14 [0.71-1.84],0.5864730330721963
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,18258,289,0.99 [0.84-1.17],0.8953990207520275
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,15777,238,1.02 [0.80-1.31],0.8621646655570581
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,18561,288,0.98 [0.62-1.52],0.9120231642897816
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,18340,284,1.26 [1.01-1.56],0.0386301537799046
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,15830,235,1.27 [0.91-1.77],0.1587132973251679
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,16062,240,1.05 [0.82-1.35],0.7086434091560136
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,16161,245,0.88 [0.74-1.05],0.1519718483194541
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,15173,224,0.98 [0.76-1.27],0.9004449712968647
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,17978,284,0.92 [0.74-1.14],0.4634025354813195
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,17415,274,0.98 [0.79-1.22],0.8537291969947383
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,18631,293,1.33 [0.98-1.80],0.0678078235324719
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,18573,287,1.00 [0.88-1.13],0.9548205670099466
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,18830,294,1.23 [0.94-1.61],0.1331312707036929
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,18367,283,1.05 [0.73-1.53],0.7800035737439521
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,18642,288,0.95 [0.73-1.24],0.7260659505533309
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,18690,293,0.86 [0.64-1.16],0.3206629581608068
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,18689,288,1.19 [0.94-1.50],0.1556389239581779
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,18830,294,1.10 [0.82-1.46],0.5318065162466495
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,15662,238,0.98 [0.81-1.17],0.7984503659499298
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,15703,236,1.06 [0.91-1.24],0.4294830102044257
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,15627,234,0.94 [0.75-1.19],0.6138417291793516
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,18230,284,0.89 [0.73-1.08],0.2305176681793022
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,15741,240,0.62 [0.41-0.94],0.0248085905652553
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,18718,292,1.11 [0.76-1.63],0.586465073274627
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,15750,234,0.78 [0.56-1.07],0.1256368344060601
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,18258,289,1.08 [0.96-1.22],0.1969029962091382
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,18608,289,0.93 [0.80-1.09],0.3757082079429508
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,15514,236,1.13 [0.96-1.34],0.1478900483973663
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,18790,294,0.96 [0.83-1.11],0.5690074024645047
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,18573,290,0.98 [0.85-1.13],0.7920903572087764
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,18192,286,1.23 [0.88-1.73],0.2228006819370915
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],18340,284,0.98 [0.81-1.20],0.8706093951671006
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,18745,294,1.32 [0.93-1.87],0.1257768643130849
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,16130,242,0.99 [0.84-1.15],0.865586373158347
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,15777,238,1.04 [0.80-1.35],0.7627839277681554
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,16136,244,0.98 [0.83-1.15],0.7605586878805366
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,16161,245,1.03 [0.80-1.33],0.8211109286410712
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,18561,288,0.97 [0.76-1.22],0.7716868780962696
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,16068,243,1.19 [0.81-1.76],0.3670086477389701
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,18778,293,0.93 [0.78-1.11],0.4228970109551736
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,18653,291,0.96 [0.78-1.18],0.6931049864257619
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,16213,244,1.28 [0.83-1.98],0.2681544667241077
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,16208,243,1.10 [0.86-1.41],0.4267864726562653
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,16213,244,1.51 [1.09-2.07],0.0118523444519333
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,16208,243,1.19 [0.70-2.05],0.5189631264286778
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,15741,240,0.95 [0.72-1.27],0.7495999509757418
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,16188,244,0.95 [0.68-1.32],0.7486264118206949
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,15496,236,1.04 [0.76-1.42],0.8157904691179865
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,16213,244,1.09 [0.92-1.29],0.3028883867282201
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,16208,243,0.90 [0.54-1.51],0.7003625504771214
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,18654,292,1.04 [0.78-1.37],0.8002396718180345
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,16208,243,1.06 [0.83-1.35],0.6304201865420893
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,18722,293,0.86 [0.61-1.23],0.4171661034038331
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,18628,290,0.92 [0.79-1.08],0.3168436335527616
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,15830,235,0.97 [0.87-1.09],0.6464709965246744
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,18474,291,1.00 [0.80-1.25],0.9901591592690904
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,15910,241,0.97 [0.81-1.16],0.7421153975875365
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,18561,288,1.28 [0.99-1.65],0.0622489978568449
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,16136,244,0.95 [0.85-1.06],0.3433257666926436
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,16168,245,1.02 [0.85-1.22],0.8336979329810102
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,18551,290,0.85 [0.69-1.03],0.1014977264586995
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",16130,242,0.88 [0.64-1.20],0.4196606673173724
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,18230,284,0.87 [0.69-1.09],0.2198689784813107
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,18230,284,0.93 [0.78-1.12],0.4545836516392126
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,15910,241,0.80 [0.56-1.14],0.2118482331322219
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,15830,235,1.01 [0.87-1.18],0.8878607794213074
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,15627,234,1.05 [0.90-1.23],0.5245759465086826
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,16161,245,1.04 [0.90-1.19],0.6151195278545378
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,16168,245,0.99 [0.87-1.13],0.8923672876715851
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,18646,290,1.02 [0.92-1.13],0.7077747970347734
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,15700,238,1.03 [0.87-1.22],0.7484253360635357
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,15700,238,0.84 [0.61-1.17],0.3039763590717403
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,18258,289,0.78 [0.58-1.04],0.0920611310433102
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,15662,238,1.18 [1.00-1.40],0.0481971093944168
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,15662,238,0.95 [0.69-1.30],0.7376808242719939
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,15700,238,0.94 [0.75-1.18],0.5786093635394292
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,18340,284,0.81 [0.59-1.11],0.192895778810472
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,15662,238,0.97 [0.76-1.25],0.837562685880694
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,18654,292,1.01 [0.80-1.27],0.9392507551301688
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,18561,288,0.93 [0.77-1.12],0.4361611708758924
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,18745,294,0.96 [0.72-1.28],0.781150127884163
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,15700,238,0.94 [0.76-1.16],0.5609804053590066
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,18340,284,1.05 [0.84-1.32],0.6655310690790511
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,16055,242,1.11 [0.85-1.45],0.4530626335528889
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,18504,291,1.01 [0.83-1.22],0.9349927381738636
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,18504,291,1.26 [0.90-1.76],0.1861590489509785
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,16208,243,1.56 [1.00-2.43],0.05087044976041
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,16189,244,0.98 [0.63-1.52],0.9181581208186592
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,16168,245,0.98 [0.81-1.18],0.831274989755752
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,15741,240,1.04 [0.92-1.18],0.5273599130279516
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,15662,238,0.98 [0.83-1.15],0.78192032430717
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,18258,289,1.05 [0.91-1.21],0.4999006291654353
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,15627,234,1.07 [0.74-1.54],0.7158815530255876
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,16136,244,1.03 [0.89-1.19],0.6619921131505633
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,18230,284,0.85 [0.70-1.02],0.0771799230547056
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,18698,293,0.96 [0.83-1.12],0.6240019323571077
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,15662,238,0.73 [0.53-1.01],0.06053794709584
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,15662,238,0.75 [0.49-1.13],0.1633279644631053
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,15662,238,0.88 [0.63-1.24],0.4664587255696335
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,15627,234,0.93 [0.68-1.26],0.6250870553545946
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,15662,238,0.90 [0.72-1.12],0.3460448466453765
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",15662,238,1.07 [0.85-1.34],0.5524505086632052
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",18710,288,0.97 [0.89-1.07],0.5943769540914272
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",18258,289,1.15 [0.91-1.44],0.2380730985251277
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,18230,284,1.08 [0.84-1.40],0.5468528926615838
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,18561,288,0.58 [0.37-0.90],0.014551851970359
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,18230,289,1.03 [0.88-1.20],0.7491442173046534
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,15741,240,0.95 [0.80-1.13],0.5817615900461085
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,15662,238,1.11 [0.99-1.26],0.0837016797620247
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,16136,244,1.13 [0.77-1.65],0.5280865158770038
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",16213,244,0.96 [0.46-2.00],0.9037826290906732
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,18258,289,1.06 [0.92-1.23],0.4159529308461074
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,15700,238,1.02 [0.91-1.14],0.727577898516813
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,16168,245,1.32 [1.06-1.63],0.0115849131632121
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,16161,245,0.93 [0.76-1.13],0.4759292286952965
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,18646,290,1.02 [0.91-1.13],0.7491382618463451
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,18745,294,0.90 [0.61-1.32],0.5898986288639946
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,16168,245,1.05 [0.85-1.31],0.6363845312721688
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,18113,288,0.83 [0.71-0.97],0.0167908240829594
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,16213,244,0.91 [0.60-1.38],0.6510653436593772
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,15662,238,0.55 [0.29-1.04],0.0675632832652592
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",15741,240,0.87 [0.62-1.22],0.4176474268923792
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",18710,288,1.25 [0.86-1.82],0.2466765204678772
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",18654,292,0.96 [0.63-1.47],0.8474015980596716
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,15703,236,0.90 [0.58-1.42],0.6591905436470495
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,18646,290,0.98 [0.85-1.13],0.7871150720365916
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,18470,291,1.05 [0.81-1.37],0.7000569194531132
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,15703,236,1.08 [0.84-1.39],0.5412045679922459
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,18323,284,1.05 [0.78-1.40],0.7538828281607278
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,18230,284,0.95 [0.80-1.13],0.5675220338384127
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,18230,284,0.91 [0.62-1.32],0.6078289749848926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,18646,290,1.01 [0.91-1.11],0.871104429720811
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,16161,245,1.05 [0.88-1.24],0.6015559532658238
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,15777,238,0.98 [0.85-1.14],0.8355590775886054
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,18226,287,0.95 [0.84-1.07],0.3709619773828223
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,18654,292,0.69 [0.44-1.07],0.0961862839438314
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,18504,291,0.84 [0.62-1.13],0.242753517503688
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",16189,244,0.87 [0.58-1.33],0.5291067429221832
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",15700,238,0.84 [0.65-1.09],0.1959212871507526
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,15912,242,1.54 [0.96-2.49],0.0761465195210198
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,16136,244,1.15 [0.94-1.41],0.1679916451433142
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,16161,245,0.97 [0.86-1.10],0.6583670599603726
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",18646,290,0.95 [0.74-1.23],0.7122551045088286
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,15703,236,0.92 [0.73-1.15],0.453635487113223
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,15627,234,1.02 [0.84-1.23],0.8776943503480855
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,16130,242,1.10 [0.86-1.40],0.4605918165007966
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,18646,290,0.99 [0.88-1.10],0.804244277446017
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,16200,246,0.99 [0.86-1.14],0.8818418509958524
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,15741,240,1.00 [0.81-1.24],0.976018873449191
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,15627,234,1.08 [0.83-1.41],0.55830911601616
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,16200,246,0.91 [0.78-1.05],0.182227170896173
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,18204,284,0.99 [0.91-1.09],0.9035520290183598
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,15700,238,0.99 [0.82-1.18],0.880148097214947
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,15662,238,1.18 [0.74-1.87],0.4969870386723315
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,18646,290,0.97 [0.83-1.13],0.6932847479314006
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,18654,292,0.96 [0.85-1.08],0.4900227783326822
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,18230,284,1.04 [0.88-1.23],0.625756912435395
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,18887,296,0.92 [0.65-1.29],0.6139329727732283
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,15703,236,1.53 [1.17-2.00],0.002026872915123
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,15700,238,1.00 [0.84-1.18],0.9681952855674952
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,16161,245,1.10 [0.82-1.48],0.5287239731085678
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,18654,292,0.86 [0.73-1.01],0.0593889074048267
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,15830,235,0.79 [0.51-1.22],0.2899037309316099
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,18470,291,1.15 [0.93-1.43],0.195912934688419
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,18293,284,1.04 [0.80-1.36],0.7723712299283471
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,15830,235,1.15 [0.66-1.99],0.6252098060209359
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,16189,244,1.07 [0.75-1.53],0.7090377319939398
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,15703,236,1.13 [0.85-1.51],0.3952421457633781
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,18323,284,1.17 [0.74-1.86],0.4926499671611163
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,15700,238,0.97 [0.76-1.23],0.7836809009002711
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,15741,240,0.83 [0.65-1.05],0.1130302964046669
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,15187,226,1.00 [0.89-1.12],0.9717985809876436
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,18627,292,0.95 [0.81-1.11],0.516066773469291
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,16161,244,0.80 [0.65-0.99],0.0431304133513933
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,15973,243,0.99 [0.88-1.10],0.7989961337738696
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,15910,241,1.03 [0.68-1.55],0.90318245782713
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,15700,238,0.78 [0.53-1.15],0.2147638926836404
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,15662,238,0.92 [0.70-1.20],0.5243300513318521
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,15662,238,0.74 [0.53-1.05],0.0922576215599437
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,18258,289,1.03 [0.81-1.29],0.8287236193792595
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,15700,238,1.14 [0.85-1.52],0.3885501201997052
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,16168,245,1.29 [0.94-1.76],0.1145310795642435
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BSG,Basigin,18842,293,1.17 [0.70-1.96],0.5482004963301434
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BSND,Barttin,15627,234,0.65 [0.43-1.00],0.0510729798268186
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,18821,295,1.01 [0.81-1.26],0.9124511066077976
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,18821,295,0.97 [0.78-1.21],0.8105246456398729
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,18230,284,1.03 [0.89-1.18],0.7260699692498453
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,16213,244,1.59 [0.86-2.92],0.1359312115933109
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,15627,234,1.03 [0.90-1.17],0.6672382361004062
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,16097,242,1.13 [0.84-1.52],0.412500736761773
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,18710,288,1.24 [0.84-1.83],0.2699095403247102
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,18646,290,0.84 [0.64-1.11],0.2193792998155777
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,15627,234,0.90 [0.65-1.26],0.5519949694128717
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,18258,289,1.07 [0.92-1.25],0.3652359739847712
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,15662,238,1.12 [0.77-1.62],0.5576889673021788
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,18784,293,0.92 [0.58-1.47],0.7366693653227401
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",16168,245,1.01 [0.86-1.20],0.8683650204141594
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,15703,236,1.02 [0.76-1.37],0.9096750475945208
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,18745,294,1.10 [0.86-1.39],0.44737467394914
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,15830,235,1.05 [0.74-1.50],0.7703432426805789
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,16168,245,0.88 [0.60-1.30],0.5148564852842674
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,15806,235,0.77 [0.61-0.99],0.0377224052301693
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,16213,244,2.22 [1.38-3.57],0.0009484659821556
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,16178,244,1.78 [0.94-3.37],0.07706788916374
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,16213,244,1.83 [1.05-3.20],0.034402087337214
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C2,Complement C2,18722,293,1.00 [0.62-1.60],0.9860689552396238
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,18230,289,0.87 [0.67-1.13],0.3102345311970078
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,15777,238,0.93 [0.74-1.17],0.5292886396206365
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C3,Complement C3,15395,235,1.11 [0.85-1.46],0.4416728718132703
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,18698,293,1.35 [1.04-1.75],0.0265939282805415
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C5,Complement C5,16213,244,1.71 [0.75-3.89],0.2020228978760833
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,15832,242,1.29 [0.87-1.91],0.2087100242139114
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,16161,245,1.23 [0.78-1.93],0.3750015497947458
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,16213,244,1.22 [0.81-1.83],0.3431675333129175
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,16208,243,1.05 [0.85-1.30],0.6583227019297122
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,16136,244,0.86 [0.74-1.01],0.065845709888517
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,18290,287,0.85 [0.71-1.02],0.0888121708538245
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,18230,284,1.06 [0.75-1.50],0.7367497358931978
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,18561,288,1.08 [0.79-1.49],0.6247949087080992
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,18427,287,0.97 [0.88-1.07],0.5408031049443458
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,18830,294,0.84 [0.63-1.12],0.2316792001995007
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,18596,292,0.84 [0.72-0.98],0.0287496509857883
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,18862,296,1.00 [0.84-1.19],0.9892508722775818
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,18887,296,1.05 [0.69-1.60],0.8102484714069949
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",18323,284,0.98 [0.87-1.10],0.6925965711940866
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,18594,290,0.98 [0.83-1.16],0.8481579656234834
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,15910,241,0.83 [0.56-1.23],0.3569805496592847
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,15703,236,1.09 [0.68-1.75],0.7237825526394014
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,18830,294,1.17 [0.95-1.44],0.1484048979446024
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,15777,238,0.94 [0.77-1.15],0.5656253778279607
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,15700,238,0.87 [0.58-1.30],0.4958135093796693
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,15662,238,1.00 [0.80-1.25],0.9978718899170896
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,15700,238,0.92 [0.74-1.14],0.4329300851956587
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,16168,245,1.02 [0.89-1.18],0.7421832053216524
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,15803,235,0.99 [0.88-1.12],0.910345490662366
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,15777,238,0.83 [0.58-1.18],0.3077412033538137
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,18561,288,1.10 [0.87-1.39],0.4337641839234951
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,18258,289,1.08 [0.75-1.57],0.6645154013946769
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,18476,291,1.03 [0.88-1.20],0.7152365472393001
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,16161,245,1.17 [0.89-1.54],0.2554650468330623
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,18775,293,1.03 [0.93-1.14],0.6202195835029269
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,15741,240,1.02 [0.87-1.21],0.7876440991055191
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,15662,238,0.81 [0.56-1.17],0.2531358798978803
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,18230,284,0.93 [0.73-1.19],0.5593224055315855
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,15777,238,1.04 [0.83-1.31],0.7291785349718138
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,16168,245,1.00 [0.89-1.12],0.9544147347082652
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,18588,289,1.10 [0.65-1.84],0.7316991723031876
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,18543,293,1.04 [0.87-1.23],0.6985467564735336
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,16130,242,1.13 [0.82-1.55],0.4676359367320575
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,16161,245,0.99 [0.88-1.12],0.8594066787843389
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,18258,289,0.88 [0.71-1.08],0.2178322404923144
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,15777,238,1.03 [0.76-1.39],0.8384011296850976
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,18258,289,1.06 [0.92-1.22],0.4320177172359116
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,18258,289,1.00 [0.87-1.16],0.9769004805822152
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,18646,290,1.04 [0.89-1.21],0.5954881431886165
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,18887,296,1.00 [0.89-1.13],0.9666888215915888
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,15910,241,1.03 [0.96-1.11],0.4552619364865822
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,16161,245,1.03 [0.89-1.19],0.7357266800837943
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,18780,293,0.98 [0.83-1.16],0.7916452475130575
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,15703,236,1.09 [0.89-1.32],0.419910124180745
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,15662,238,1.00 [0.77-1.29],0.9960455634237
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAT,Catalase,15971,238,0.75 [0.59-0.96],0.0217778511030663
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,18633,291,1.06 [0.93-1.20],0.4222488533823433
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,15700,238,0.96 [0.83-1.11],0.5899980564396322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,18830,294,1.28 [0.95-1.71],0.0996386514243388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,15741,240,0.97 [0.76-1.25],0.8232897436731001
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,15662,238,0.79 [0.54-1.16],0.2277081493106341
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,18504,291,0.96 [0.83-1.11],0.5757708648416834
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,16161,245,1.01 [0.81-1.26],0.9108428055161224
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,16130,242,1.18 [0.92-1.51],0.1948581596847625
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,15777,238,0.79 [0.52-1.19],0.2591371964367689
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,16168,245,1.00 [0.85-1.17],0.9650181386937944
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,18653,291,1.11 [0.83-1.47],0.4871057547788151
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,15741,240,0.97 [0.79-1.19],0.7576001444107059
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,18876,294,0.94 [0.71-1.24],0.6566104676725273
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,18849,294,0.87 [0.75-1.01],0.0697105410184243
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,18631,293,0.97 [0.74-1.25],0.7979213347519193
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,18887,296,1.29 [1.03-1.61],0.0287509260936065
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,18887,296,1.04 [0.85-1.28],0.6747712728811057
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,18592,288,0.99 [0.88-1.11],0.8530919858950234
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,18429,290,0.89 [0.76-1.05],0.1647711540661683
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,18821,295,0.99 [0.91-1.08],0.889257257544577
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,18470,291,0.80 [0.66-0.98],0.0341445071335768
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,18876,294,1.01 [0.90-1.13],0.8883503497090045
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,18710,288,1.08 [0.83-1.41],0.5595666413738742
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,18433,288,1.04 [0.85-1.27],0.7070394404255342
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,18710,288,1.09 [0.85-1.40],0.4999855401441501
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,18689,288,0.91 [0.80-1.03],0.127067526450853
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,18876,294,1.17 [0.95-1.45],0.1336723014674248
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,18646,290,0.99 [0.89-1.11],0.9246442446825
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,18653,291,0.96 [0.81-1.14],0.6286101519690463
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,18583,290,1.02 [0.86-1.22],0.7968950998394642
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,18646,290,0.99 [0.80-1.21],0.8961523117441818
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,18652,288,0.90 [0.76-1.08],0.2563423367650103
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,18745,294,0.97 [0.88-1.08],0.6076654009374635
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,18646,290,0.93 [0.77-1.13],0.4614624199267922
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,18804,294,0.89 [0.75-1.05],0.1652903412943508
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,18535,288,0.99 [0.86-1.15],0.9400605530098116
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,18636,288,0.87 [0.72-1.06],0.1635235323848382
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,18849,295,0.91 [0.66-1.25],0.5573869586096474
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,18830,294,1.05 [0.80-1.38],0.7063565078561664
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,18654,292,1.07 [0.81-1.40],0.6460010408395106
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,15910,241,0.93 [0.66-1.30],0.6780481929322568
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,15703,236,0.98 [0.85-1.14],0.8320532113323368
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,18504,291,0.90 [0.72-1.13],0.3769224505529571
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,18230,284,0.90 [0.71-1.16],0.4187029506980634
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,16136,244,1.06 [0.80-1.40],0.6967033035485257
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,18654,292,1.18 [0.86-1.62],0.296150770235893
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,18317,290,1.14 [0.89-1.48],0.3028189656438998
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,18876,294,1.08 [0.87-1.34],0.4619992710419993
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,18745,294,1.03 [0.81-1.31],0.8344666637793983
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,18654,292,1.37 [1.01-1.87],0.0427375977288045
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,15777,238,1.20 [0.87-1.64],0.2645967039970386
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,18622,292,1.02 [0.94-1.11],0.6048422378896148
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,18698,293,1.15 [0.75-1.76],0.5222122816781993
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,15662,238,1.09 [0.81-1.47],0.5709257989915807
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,18646,290,0.97 [0.65-1.44],0.8790617251974537
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,18580,290,1.16 [0.87-1.55],0.3090234331265041
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,18220,286,0.89 [0.68-1.17],0.4057231909465626
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,18704,294,0.94 [0.72-1.23],0.6589288447892149
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,18876,294,1.12 [0.88-1.43],0.3532355358797799
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,15703,236,1.10 [0.82-1.48],0.5212203936057056
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,18876,294,1.23 [0.85-1.78],0.2690485460036528
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,16200,246,1.00 [0.74-1.36],0.9796581362723812
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,18698,293,1.05 [0.81-1.35],0.7242319544648129
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,18504,291,1.27 [0.94-1.73],0.1174711237408874
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,18620,288,1.05 [0.79-1.41],0.7286244820968455
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,18230,284,1.14 [0.86-1.50],0.3592049140355853
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,18653,291,0.97 [0.82-1.14],0.6828209550275955
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,15830,235,1.02 [0.67-1.54],0.9354741501735696
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,18821,295,1.21 [0.90-1.61],0.2040456391518687
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,18776,294,1.02 [0.79-1.31],0.8985146982978449
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,18830,294,1.15 [0.96-1.38],0.1242695060316759
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,18654,292,0.75 [0.57-0.99],0.0457133022447689
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,18561,288,1.33 [0.96-1.86],0.0857259951859223
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,18698,293,0.97 [0.86-1.11],0.6923038048105665
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,18761,295,1.11 [0.72-1.70],0.6321094733146142
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,15703,236,1.09 [0.83-1.43],0.528472681768386
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,18561,288,0.93 [0.68-1.29],0.6805045584712551
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,15700,238,0.74 [0.48-1.13],0.1602237394356396
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,15910,241,1.04 [0.74-1.44],0.8327696253846962
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,15703,236,0.98 [0.84-1.13],0.7432131109855815
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,18614,290,0.95 [0.66-1.36],0.7828794891284566
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,18631,288,1.01 [0.82-1.25],0.9068632908853238
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,18876,294,0.97 [0.86-1.11],0.6774768830748299
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,18575,291,1.10 [0.77-1.58],0.5972846495490434
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,18689,288,1.32 [0.93-1.87],0.1227843140018715
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,18804,294,1.39 [1.04-1.87],0.0284066723525373
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,18023,278,0.98 [0.66-1.46],0.9244963021376866
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,18584,286,1.09 [0.60-1.97],0.7841100390045859
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,18010,285,0.93 [0.58-1.48],0.7556501475131838
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,16145,244,1.04 [0.80-1.34],0.7917451083441283
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,18842,293,1.19 [0.97-1.45],0.0939754840245811
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,18470,291,0.85 [0.70-1.05],0.1343448416818702
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,18561,291,1.01 [0.89-1.13],0.9229171106623756
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,15675,235,1.12 [0.85-1.49],0.4235923084822104
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,18646,290,0.97 [0.76-1.24],0.8038622730076366
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,15830,235,1.16 [0.85-1.57],0.347363071277424
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,18821,295,1.08 [0.79-1.47],0.6292068011911719
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,18876,294,1.00 [0.79-1.27],0.9966946528511668
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,16189,244,1.19 [0.83-1.73],0.3461840973439425
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,15910,241,1.04 [0.76-1.41],0.8097982320427727
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,18646,290,1.02 [0.75-1.39],0.8953469872529449
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,18646,290,1.10 [0.79-1.53],0.5592323156622416
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,16136,244,1.12 [0.74-1.70],0.6006761650788237
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,18821,295,1.30 [1.08-1.57],0.0063658260747858
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,17974,279,1.06 [0.75-1.49],0.7599663027936312
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,18654,292,1.07 [0.63-1.81],0.8061225858953462
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,18654,292,1.00 [0.65-1.52],0.9937993977459476
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,16168,244,0.70 [0.53-0.92],0.0109588839899643
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,16161,245,1.26 [0.76-2.07],0.3709930470255104
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,15627,234,1.08 [0.89-1.30],0.4341551394992456
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,15627,234,0.97 [0.69-1.35],0.8464830483070006
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,16098,244,1.03 [0.86-1.23],0.7435816442989627
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,18230,284,1.00 [0.84-1.19],0.9953691779111052
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,18698,293,0.99 [0.88-1.12],0.898306372768329
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,16136,244,1.05 [0.93-1.18],0.4541302684478291
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,18504,291,1.00 [0.83-1.20],0.9879677831771666
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,18048,280,1.21 [0.94-1.56],0.1334865064912304
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,18793,295,1.02 [0.89-1.17],0.7729588044286675
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,18653,291,1.22 [1.06-1.41],0.0053602488302419
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,18653,291,1.08 [0.80-1.46],0.6085109875096297
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,15910,241,0.80 [0.50-1.27],0.3449943735654672
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,16161,245,1.09 [0.69-1.72],0.7029952417813017
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,18821,295,1.06 [0.80-1.40],0.7032165605829339
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,15700,238,0.97 [0.74-1.27],0.8169899233256769
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,18887,296,0.87 [0.62-1.23],0.4293444359002279
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,18653,291,0.93 [0.71-1.22],0.5969741371475812
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,18258,289,1.07 [0.84-1.37],0.5855921864372481
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,18561,288,0.90 [0.77-1.06],0.2111832621898802
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,18653,291,1.25 [0.95-1.64],0.1150994864466749
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,15627,234,1.37 [0.97-1.94],0.0706614293153595
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,16168,245,0.73 [0.58-0.93],0.0092153780013953
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,15700,238,0.86 [0.66-1.12],0.268913485703769
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,18561,288,1.03 [0.94-1.14],0.5351585979695005
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,18561,288,0.97 [0.87-1.08],0.5327870324828825
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,18561,288,0.97 [0.70-1.33],0.8382751340728584
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,18650,288,1.11 [0.74-1.67],0.6070384475031386
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,18824,293,0.92 [0.73-1.17],0.4970523042727818
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,18670,292,0.96 [0.58-1.59],0.8795561019318796
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,16136,244,0.99 [0.85-1.16],0.9256217792748348
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,15910,241,1.15 [0.99-1.33],0.0680964805764722
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,16136,244,0.79 [0.58-1.07],0.1297052882429979
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,15910,241,1.00 [0.75-1.32],0.9753432593384164
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,18646,290,1.03 [0.92-1.17],0.5797752232641932
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,18230,284,0.84 [0.66-1.07],0.1629759831173029
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,17991,280,1.11 [0.94-1.32],0.2235238171093588
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,16200,246,0.91 [0.67-1.24],0.540649538877005
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,18323,284,0.86 [0.69-1.07],0.1673845254519493
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,15703,236,1.09 [0.78-1.53],0.5944905734137259
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,18323,284,0.84 [0.63-1.12],0.2217768763006019
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,16200,246,0.97 [0.80-1.17],0.7316455201822111
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,18856,296,1.04 [0.88-1.23],0.6814574117674288
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,15830,235,0.67 [0.43-1.05],0.080009416715663
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,15703,236,1.16 [0.78-1.73],0.458283316062522
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,15700,238,0.71 [0.54-0.94],0.0169684774165385
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,15910,241,0.92 [0.73-1.17],0.5114172079064768
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,15910,241,1.04 [0.87-1.23],0.6884177030386167
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,15662,238,0.88 [0.65-1.19],0.4148773992788128
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,15627,234,1.04 [0.78-1.39],0.7984297924463191
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,18340,284,0.99 [0.83-1.18],0.9021958395081816
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,15741,240,1.00 [0.84-1.18],0.9570727993194702
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,18230,284,0.98 [0.85-1.13],0.800418520016376
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,15910,241,0.94 [0.74-1.19],0.5950676824423695
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,15627,234,1.00 [0.71-1.41],0.9931633703589232
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,18183,284,0.95 [0.81-1.10],0.4831707997204013
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,18230,284,0.98 [0.83-1.16],0.786105317059687
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,18258,289,0.94 [0.79-1.11],0.446396252106481
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,18700,294,1.03 [0.91-1.16],0.6279484851737447
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,18561,288,0.99 [0.82-1.20],0.9373269990785708
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,18561,288,1.04 [0.90-1.20],0.606795628559064
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,18258,289,0.96 [0.82-1.12],0.6227493363462515
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,16136,244,1.04 [0.89-1.22],0.6363839562589071
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,15942,243,1.13 [0.77-1.66],0.5169734059089978
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,18230,284,0.89 [0.70-1.14],0.3600131734919288
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,16213,244,0.80 [0.44-1.46],0.4676364250355893
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,15301,230,1.26 [0.73-2.18],0.4043324419351
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,16098,243,0.79 [0.64-0.96],0.017593549680283
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,16178,243,1.10 [0.92-1.30],0.304777672634436
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,16009,242,1.14 [0.84-1.54],0.4170799913973175
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,16213,244,1.68 [0.89-3.16],0.1084351884432114
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFP,Properdin,16213,244,1.13 [0.66-1.95],0.6569883745549825
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,18654,292,1.22 [1.04-1.42],0.0136253789390516
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,16208,243,1.10 [0.79-1.54],0.5802110213276178
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,15777,238,0.80 [0.55-1.14],0.2180994543527211
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,18653,291,1.14 [0.90-1.45],0.2762705050322653
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,18230,284,0.86 [0.71-1.04],0.1127775597291456
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,15830,235,0.96 [0.73-1.25],0.7401676968377702
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",16161,245,1.31 [1.00-1.72],0.0542686105599596
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,16130,242,1.19 [0.78-1.82],0.4119298746584365
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,18323,284,1.22 [0.88-1.69],0.2249267593304159
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,16200,246,1.13 [1.00-1.28],0.0460864575833827
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,18771,295,0.86 [0.67-1.11],0.2426969269872486
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,18273,284,0.98 [0.86-1.11],0.7267129594850069
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,18744,295,1.02 [0.96-1.09],0.5458030243899115
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,18718,294,1.03 [0.73-1.46],0.8464898534361691
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,15777,238,1.00 [0.81-1.23],0.9795809300546546
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,18504,291,0.94 [0.82-1.07],0.3388575109914762
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,16189,244,0.99 [0.80-1.23],0.9552821614263256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,15700,238,0.87 [0.72-1.05],0.1408432243181035
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,18689,288,0.82 [0.59-1.14],0.2326996778742591
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,18653,291,1.02 [0.81-1.27],0.8941827675502735
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,15777,238,0.97 [0.69-1.38],0.882122783457541
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,18698,293,0.96 [0.81-1.13],0.6148771292475306
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,16200,246,0.99 [0.79-1.24],0.9372761045561322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,15910,241,0.94 [0.70-1.25],0.6581390467861692
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,16136,244,0.96 [0.85-1.09],0.5497464644612231
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,15777,238,0.86 [0.65-1.14],0.2824210182924571
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,18784,293,1.35 [0.97-1.88],0.075558000337475
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,16200,246,1.06 [0.86-1.32],0.5829504811966387
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",18565,286,1.15 [0.98-1.36],0.0860086385202633
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,15627,234,1.00 [0.84-1.18],0.9928714675075928
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,18623,290,0.99 [0.85-1.16],0.9271758432587052
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,18504,291,1.01 [0.75-1.34],0.969269055597472
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,18626,292,0.99 [0.80-1.23],0.9319192665673448
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,15703,236,1.70 [0.97-2.99],0.063314120023452
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,18654,292,1.17 [0.86-1.61],0.321046995776177
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,18323,284,0.90 [0.66-1.23],0.5157377760111735
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,18821,295,1.02 [0.91-1.13],0.7367588209535534
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,15777,238,0.92 [0.70-1.19],0.5087879157925206
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,15854,243,0.88 [0.49-1.56],0.6534015702224714
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,18646,290,0.78 [0.59-1.04],0.0929644047804656
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,18646,290,1.05 [0.85-1.30],0.658982830368152
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,18646,290,0.93 [0.78-1.10],0.3825268217257498
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,18646,290,1.14 [0.84-1.56],0.3946939791771432
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,16178,246,0.94 [0.73-1.21],0.6298238701743548
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,18593,291,0.98 [0.70-1.39],0.92432193866156
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,18230,284,1.09 [0.87-1.37],0.4547067068315188
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,18876,294,1.07 [0.90-1.29],0.430024308209759
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,15777,238,1.03 [0.79-1.35],0.8226296827850472
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,15777,238,1.09 [0.74-1.60],0.670330707143439
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,15627,234,0.98 [0.75-1.29],0.9002397864433053
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,18646,290,1.02 [0.93-1.12],0.6781380616415539
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,18830,294,0.96 [0.60-1.54],0.8535892178376435
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,15777,238,0.83 [0.57-1.21],0.3280842525830247
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",18476,291,1.00 [0.89-1.11],0.9371913060112328
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,18616,292,1.01 [0.88-1.16],0.9128562407661426
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,18230,289,1.08 [0.84-1.40],0.5424088600780661
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,18258,289,0.88 [0.71-1.08],0.2232799335084061
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,18876,294,1.13 [0.87-1.46],0.3569777194675076
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,16161,245,1.57 [1.09-2.28],0.0164800985924523
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,18323,284,0.89 [0.70-1.13],0.3556883090501392
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,16213,244,1.43 [1.06-1.94],0.021021382815245
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,18617,289,1.02 [0.81-1.29],0.8614904924553604
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,16189,244,1.01 [0.89-1.16],0.8386316849649033
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,16130,242,1.05 [0.90-1.21],0.5431229589996615
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,18745,294,0.98 [0.79-1.23],0.88134744109315
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,15700,238,0.94 [0.74-1.21],0.6430008438192358
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",15712,239,0.99 [0.84-1.16],0.8643952432800206
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,18323,284,0.90 [0.74-1.09],0.2616319238125176
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,18561,288,1.00 [0.87-1.15],0.9893275435126804
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNST,Consortin,18653,291,1.01 [0.92-1.11],0.885666126548578
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,15700,238,0.93 [0.65-1.34],0.7099731172163852
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,18887,296,1.20 [0.82-1.76],0.3537299334086543
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,18830,294,1.11 [0.88-1.39],0.3944767470884611
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,18654,292,1.24 [0.85-1.80],0.2738869343619722
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,18654,292,1.19 [0.76-1.84],0.4474598776020673
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,18704,293,0.95 [0.71-1.26],0.7041804763143611
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,18646,290,1.06 [0.83-1.35],0.6569816955654857
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,15777,238,1.04 [0.93-1.16],0.5352576774688014
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,16189,244,1.02 [0.78-1.33],0.880134350931313
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,16200,246,0.81 [0.51-1.28],0.3706993037974578
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,18731,295,1.07 [0.69-1.65],0.7679502664633427
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,18887,296,0.96 [0.62-1.49],0.8575343774502021
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,16136,244,0.95 [0.77-1.17],0.6046985677653781
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,15777,238,1.02 [0.87-1.19],0.8356661769475804
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,15741,240,1.04 [0.88-1.21],0.6645655657182966
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,16200,246,1.20 [0.71-2.02],0.5007704170041523
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,18653,291,1.01 [0.77-1.32],0.9560228853983984
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,15881,241,1.00 [0.80-1.26],0.9808524771561372
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,15830,235,1.13 [0.82-1.55],0.4619728105950125
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,18887,296,1.05 [0.79-1.41],0.7165882931266823
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,18646,290,1.05 [0.84-1.32],0.677689262752708
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,15910,241,0.96 [0.72-1.28],0.7640143891276996
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,18620,288,1.14 [0.78-1.68],0.4936268792799543
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,15741,240,0.98 [0.80-1.21],0.8852748047552651
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,16130,242,0.93 [0.68-1.28],0.6653941723561867
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,18480,289,1.07 [0.78-1.47],0.6573830374784256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,18120,278,0.99 [0.87-1.13],0.8652142770237322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',15662,238,1.01 [0.77-1.34],0.917240732217526
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,18258,289,0.87 [0.68-1.10],0.2465968972184049
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",15741,240,0.91 [0.66-1.23],0.5289214642107948
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,18286,286,0.99 [0.88-1.12],0.8775194232014446
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,15700,238,1.02 [0.73-1.43],0.9062252381846344
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",18561,288,0.97 [0.83-1.13],0.6809522594327584
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,16189,244,1.08 [0.74-1.57],0.6908012913878343
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,18887,296,1.05 [0.90-1.23],0.5092493161360963
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,18766,293,1.08 [0.93-1.26],0.2989981941431577
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,15525,230,0.91 [0.68-1.23],0.5422965358931445
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,18887,296,1.02 [0.87-1.21],0.7725596658728531
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,16188,244,1.01 [0.59-1.75],0.9598376555992112
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,18668,292,1.09 [0.83-1.42],0.5424741983609452
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,15627,234,1.13 [0.80-1.60],0.4891699745985176
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,18734,294,1.43 [1.06-1.93],0.0203195067299521
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",15703,236,1.20 [0.77-1.88],0.4153314704578543
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,18821,295,1.04 [0.89-1.22],0.5889903989303282
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,16172,245,1.01 [0.72-1.43],0.9416944988420672
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,15662,238,0.64 [0.44-0.93],0.0189807723006364
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,18794,293,1.20 [0.93-1.55],0.1658080813698469
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,18698,293,0.97 [0.84-1.13],0.7106163723266634
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,16189,244,0.94 [0.58-1.52],0.7940726396267344
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,16152,243,1.08 [0.76-1.53],0.6775325721370637
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,18745,294,1.31 [1.05-1.63],0.0152968797944414
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,18230,284,1.01 [0.89-1.15],0.8236897277713602
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,18476,291,0.93 [0.81-1.07],0.3144235875414323
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,15627,234,1.08 [0.86-1.34],0.5205243656552261
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,15627,234,1.05 [0.65-1.69],0.8356453751313357
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,18408,288,0.86 [0.67-1.12],0.2753172894616188
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,15830,235,1.07 [0.76-1.51],0.7118953629103963
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,18689,288,1.23 [1.01-1.50],0.0426651052744041
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,18204,284,0.87 [0.77-0.99],0.0304849747837914
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,18620,288,1.34 [0.91-1.96],0.1401389724679554
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,18323,284,1.06 [0.90-1.26],0.4818569233719028
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,18710,288,1.41 [0.84-2.36],0.1923453010780729
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,18504,291,0.91 [0.68-1.22],0.5224710420911907
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,18830,294,0.89 [0.74-1.07],0.2164175636744382
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,16050,239,0.59 [0.38-0.93],0.0242320658963904
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,18653,286,1.01 [0.92-1.12],0.8141722736110951
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,18710,288,1.15 [0.76-1.75],0.5138093445619205
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,18128,286,1.07 [0.91-1.24],0.4117486289509857
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,18887,296,1.11 [0.79-1.55],0.5482958243563762
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,18504,291,1.07 [0.87-1.32],0.5072324588947962
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,15777,238,0.87 [0.66-1.15],0.3283438090092679
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,18323,284,0.99 [0.90-1.10],0.8647848138342682
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,16189,244,1.01 [0.84-1.23],0.8861007035138916
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,16161,245,1.02 [0.87-1.19],0.79747968797455
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,16161,245,0.98 [0.86-1.11],0.7717255965774472
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,15700,238,1.00 [0.84-1.20],0.9675418674517876
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,15741,240,0.98 [0.85-1.12],0.7301117215480631
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,15662,238,0.98 [0.88-1.09],0.7309066314611485
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,18710,288,1.33 [0.90-1.96],0.1497401137181214
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,16208,243,1.01 [0.74-1.38],0.9370367671827026
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,15662,238,1.03 [0.73-1.45],0.8839152688669621
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,18504,291,0.98 [0.82-1.16],0.7803794718974623
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,15703,236,1.10 [0.82-1.49],0.5286451532805476
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,18340,284,1.09 [0.88-1.35],0.435029292236185
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,15703,236,1.15 [0.75-1.78],0.5119337914106048
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,16208,243,1.14 [0.75-1.74],0.52884372011144
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,15703,236,0.89 [0.73-1.10],0.2956789455791764
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,16168,245,0.91 [0.69-1.20],0.4939643167481635
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,16200,246,0.97 [0.67-1.40],0.8617642451357579
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,15700,238,0.77 [0.58-1.03],0.0764466721635388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,15662,238,1.14 [1.02-1.28],0.0214521273944946
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,14052,203,0.98 [0.85-1.12],0.7219719089129317
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,18709,293,1.03 [0.72-1.47],0.8800606167063492
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,18271,288,0.90 [0.74-1.08],0.2542546423343756
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,18178,289,0.93 [0.76-1.15],0.5238147599627625
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,18652,288,1.07 [0.97-1.19],0.1804372726437064
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,18406,294,0.97 [0.76-1.23],0.7773263447829514
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,15883,241,1.13 [0.89-1.44],0.3150150523185719
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,15983,239,0.96 [0.60-1.54],0.871412739723856
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,18323,284,0.96 [0.85-1.09],0.5481391274063715
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,16200,246,1.01 [0.66-1.56],0.9471646890067664
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,16200,246,1.02 [0.70-1.50],0.9189449861015782
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,15700,238,1.02 [0.71-1.46],0.9337143599405466
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,18654,292,1.11 [0.93-1.33],0.2317121820361573
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,18620,288,1.06 [0.91-1.25],0.4509027864461931
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,16161,245,1.02 [0.86-1.21],0.8079520720468121
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,18663,295,0.95 [0.78-1.15],0.5946972135952047
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,18584,286,0.84 [0.66-1.06],0.1467669181512356
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,17447,262,0.95 [0.73-1.25],0.7163572445951922
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,15830,235,1.07 [0.84-1.36],0.5886433749848323
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,18698,293,0.90 [0.69-1.16],0.4054305963919707
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,18261,284,0.99 [0.86-1.13],0.8428526865726259
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,18653,291,1.28 [0.84-1.94],0.253004026902756
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,18876,294,1.42 [1.03-1.95],0.0304625791855463
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,14723,230,1.13 [0.66-1.94],0.6531059278034558
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,18759,292,1.02 [0.79-1.31],0.8975667726290593
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,18684,291,1.01 [0.73-1.40],0.951118140001318
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,15777,238,0.74 [0.51-1.07],0.1058212154517823
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,16043,242,1.02 [0.84-1.25],0.81314578118003
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,18504,291,0.82 [0.60-1.14],0.236732454686781
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,18646,290,1.19 [0.96-1.47],0.1108738503978619
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,18600,288,1.08 [0.97-1.20],0.1780467846481308
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,18710,288,1.03 [0.87-1.21],0.7468803569871094
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,18821,295,0.93 [0.81-1.07],0.312697591700967
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,18340,284,0.89 [0.68-1.16],0.3865053054189791
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,18821,295,1.01 [0.85-1.21],0.9132701984994844
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,18340,284,0.99 [0.81-1.20],0.891086440061279
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,18856,296,1.05 [0.67-1.64],0.8313619090778599
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,18876,294,1.22 [0.96-1.53],0.0979202373886733
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,18631,288,1.05 [0.94-1.17],0.3660292040547861
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,18589,289,1.05 [0.96-1.16],0.2593712865697307
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,18876,294,1.03 [0.90-1.18],0.6716653240760964
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,18548,292,0.97 [0.83-1.13],0.6905474862101469
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,18710,288,1.02 [0.86-1.20],0.8424317325999772
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,15627,234,0.87 [0.71-1.06],0.1706091770498398
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,15971,243,1.13 [0.91-1.41],0.2683158729274192
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",15662,238,1.02 [0.88-1.17],0.7997762000043573
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,15627,234,0.93 [0.78-1.12],0.4595775603822449
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,16200,246,0.83 [0.51-1.35],0.4619812870735377
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,15830,235,0.97 [0.83-1.13],0.658677895836373
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,18830,294,0.99 [0.90-1.08],0.8211252344065791
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,18710,288,1.05 [0.84-1.31],0.6775932478195231
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,15703,236,1.14 [0.93-1.39],0.1975801649441469
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,15703,236,1.02 [0.81-1.27],0.889997146544819
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,18646,290,0.99 [0.91-1.08],0.8391362930419575
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",18476,291,0.98 [0.85-1.13],0.7806613775291679
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,16187,243,0.97 [0.88-1.08],0.637390245945899
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,18567,292,0.98 [0.85-1.12],0.7499823452521983
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,15703,236,1.09 [0.85-1.40],0.4934540393997184
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,18710,288,0.99 [0.89-1.11],0.8729818167481457
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",18698,293,1.24 [0.93-1.66],0.1490538824064214
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,15777,238,1.09 [0.63-1.89],0.7504112851182281
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,15627,234,1.02 [0.83-1.25],0.8507274654305701
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,15627,234,1.11 [0.75-1.64],0.6100150910888522
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCN,Decorin,18323,284,0.90 [0.57-1.41],0.6393538889489212
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,15830,235,0.99 [0.86-1.13],0.8455360648051737
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,18830,294,0.97 [0.83-1.15],0.7504348074875605
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,18561,288,0.97 [0.87-1.09],0.626637301793907
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,18258,289,0.97 [0.84-1.13],0.700148904490143
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,18653,291,1.32 [0.95-1.84],0.0985857541371989
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,15700,238,0.98 [0.83-1.16],0.8025688211961036
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,15627,234,1.01 [0.86-1.18],0.9099186529983572
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,18698,293,0.94 [0.78-1.15],0.5586294924632877
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,15662,238,1.03 [0.75-1.42],0.8632896275561318
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",18561,288,1.18 [0.94-1.49],0.1619492527363069
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,18633,291,1.19 [0.95-1.48],0.1250611229391478
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,16168,245,1.03 [0.85-1.24],0.7690620617477762
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,15830,235,0.84 [0.71-0.99],0.0374694208898102
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,18821,295,0.93 [0.59-1.45],0.7394671495807051
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,16200,246,0.78 [0.58-1.07],0.1211016779059781
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,16136,244,0.91 [0.70-1.19],0.4816411196922193
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,15777,238,1.04 [0.74-1.47],0.7988521535771378
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,15703,236,1.40 [0.92-2.13],0.1121789035302458
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,15703,236,1.12 [0.91-1.38],0.2753088735083023
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,15777,238,1.04 [0.75-1.46],0.7991861591415601
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,18230,284,0.95 [0.78-1.15],0.5937461946468849
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",18646,290,0.99 [0.89-1.11],0.8850608083778722
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,18309,289,0.83 [0.68-1.02],0.0830075926119909
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,15593,233,0.80 [0.57-1.12],0.1929947161907871
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,15700,238,0.81 [0.63-1.04],0.1011055599256311
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,15700,238,0.91 [0.75-1.10],0.3227092692317503
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,15700,238,0.99 [0.79-1.25],0.9584569703974564
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,18365,287,0.96 [0.90-1.04],0.3264834123557841
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,15662,238,0.94 [0.72-1.23],0.6546246791127572
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,15703,236,0.98 [0.78-1.22],0.8460765435807358
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,18876,294,0.99 [0.85-1.16],0.9238673049502222
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,15700,238,1.12 [0.85-1.48],0.4031951155073539
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,15703,236,1.09 [0.87-1.38],0.4419899183823838
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,18340,284,0.83 [0.61-1.13],0.2345548614119991
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,15662,238,1.14 [0.90-1.46],0.2799190537624026
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,16130,242,1.01 [0.75-1.38],0.9245771425006576
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,16161,245,1.03 [0.80-1.34],0.8166835281244926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",18593,291,1.00 [0.91-1.10],0.9583749053178588
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,15777,238,0.74 [0.53-1.04],0.0807122029738807
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,15830,235,0.85 [0.54-1.34],0.4870822519699925
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,18821,295,0.97 [0.82-1.16],0.7629562007073385
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,18887,296,1.11 [0.78-1.57],0.5677055591181177
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,18470,290,0.92 [0.73-1.16],0.475918631620712
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,18561,288,1.06 [0.94-1.21],0.327442105820509
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,16161,245,1.04 [0.88-1.23],0.6455220651940574
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,16168,245,0.98 [0.76-1.26],0.8548547941137907
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,18887,296,1.15 [0.96-1.37],0.131535853802124
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,18698,293,1.13 [0.81-1.59],0.4693135025496866
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,15741,240,0.95 [0.82-1.10],0.4940492850895139
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,15741,240,1.27 [1.00-1.60],0.0487772745855706
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,15741,240,1.04 [0.82-1.30],0.760086685519439
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,15627,234,1.12 [0.87-1.45],0.3837031075410466
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,18818,294,0.98 [0.87-1.12],0.8036466513546866
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,16161,245,0.82 [0.69-0.97],0.0239812735765158
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,18561,288,0.93 [0.82-1.05],0.2486938533957443
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,16136,244,1.04 [0.86-1.26],0.6827795874209426
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,15830,235,0.81 [0.63-1.03],0.087603696657015
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,15687,234,0.98 [0.84-1.14],0.7733743999236778
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,18323,284,0.90 [0.74-1.11],0.3254894584707646
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,16161,245,1.22 [0.90-1.64],0.2055116347658466
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,15741,240,1.01 [0.87-1.17],0.922028045129658
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,16136,244,0.96 [0.81-1.12],0.5852545627222778
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,18591,288,1.05 [0.70-1.57],0.8168966761523787
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,15700,238,0.95 [0.80-1.11],0.4992083254568118
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,16136,244,0.94 [0.84-1.04],0.2324547721112757
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,16168,245,0.94 [0.75-1.19],0.6207752556944308
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,18504,291,0.99 [0.83-1.19],0.9507001101852404
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,16161,245,1.01 [0.81-1.27],0.8954805639133527
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,18674,286,0.87 [0.71-1.07],0.1878515899804403
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,15777,238,0.57 [0.37-0.89],0.0133447911659494
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,15700,238,0.93 [0.83-1.05],0.2348141548507808
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,16161,245,1.00 [0.92-1.09],0.9786776152239628
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,18653,291,1.02 [0.93-1.11],0.7000786331322268
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,18476,291,0.90 [0.72-1.12],0.3303413063722258
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,18561,288,0.92 [0.65-1.30],0.6440809594739115
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,18646,290,1.10 [0.83-1.46],0.5176303729979037
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,18331,287,0.96 [0.65-1.42],0.8530769414190915
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,18561,288,1.00 [0.74-1.36],0.9853874270254808
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,18513,290,0.96 [0.81-1.13],0.5931477414515981
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,18887,296,1.45 [0.95-2.20],0.0846628233243434
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,18778,293,1.00 [0.84-1.19],0.9774096147453024
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,18504,291,1.05 [0.82-1.35],0.6790714573573
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,18561,288,1.01 [0.84-1.21],0.9263269863044544
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,18418,285,1.11 [0.82-1.50],0.4993722951945756
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,16168,245,1.22 [0.87-1.71],0.2446779553594051
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,18654,292,0.78 [0.53-1.15],0.2116037656700433
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,18771,294,1.00 [0.74-1.34],0.9961118106992876
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,18496,288,0.92 [0.74-1.14],0.4530452741017458
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,15830,235,0.96 [0.83-1.11],0.6094272450081946
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,16092,242,1.34 [1.03-1.75],0.0291237824932736
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,15777,238,0.96 [0.78-1.19],0.7254279852488681
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,18561,288,0.99 [0.64-1.54],0.96272580009887
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,16189,244,0.92 [0.76-1.10],0.3575966514522465
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,18323,284,1.01 [0.87-1.17],0.9331818615149348
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,16130,242,1.09 [0.82-1.46],0.5530817990703181
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,15777,238,0.99 [0.82-1.20],0.912340839387378
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,18258,289,0.97 [0.86-1.10],0.6794228155300853
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",16136,244,0.96 [0.85-1.08],0.5070400034893032
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,16161,245,0.93 [0.71-1.23],0.6217405884320029
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,16130,242,1.00 [0.77-1.30],0.9899282693175286
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,15777,238,1.00 [0.85-1.17],0.9916312616975071
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,16130,242,1.19 [0.90-1.57],0.2127638698214106
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,18504,291,0.99 [0.89-1.11],0.8855586142224111
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,18806,293,1.09 [0.77-1.54],0.6209530563998986
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,18258,289,1.03 [0.78-1.37],0.8184896186817723
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",16189,244,1.01 [0.86-1.20],0.8926919276187991
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",15741,240,0.98 [0.86-1.12],0.7852215461135009
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,15662,238,1.05 [0.86-1.28],0.6531814258357687
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,15788,239,0.91 [0.65-1.26],0.5577818483669259
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,15700,238,1.02 [0.80-1.29],0.8781987583519366
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,18830,294,1.09 [0.84-1.41],0.5199574658818655
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,18646,290,0.98 [0.87-1.10],0.7552136370526302
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,16130,242,0.93 [0.75-1.14],0.4827054991182897
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,15662,238,0.81 [0.55-1.18],0.2681331686704902
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,16168,245,1.07 [0.90-1.27],0.42223439005524
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,18323,284,1.07 [0.79-1.45],0.6682042115533146
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,15741,240,1.27 [0.83-1.93],0.2751556842285046
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,15703,236,1.11 [0.85-1.45],0.4573501031491463
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,16189,244,1.03 [0.90-1.17],0.7013317180208009
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,16136,244,0.90 [0.58-1.40],0.6524582725460379
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,15910,241,1.06 [0.74-1.51],0.7608784202041032
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,18715,294,1.04 [0.75-1.44],0.8126439167676093
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,16168,245,1.01 [0.72-1.43],0.9448539823843856
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,18623,292,1.18 [0.83-1.68],0.3449835099228668
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,18470,291,1.21 [0.87-1.68],0.258256358594147
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,15777,238,0.94 [0.75-1.20],0.6327286802274733
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,18600,288,0.99 [0.89-1.09],0.7743477147039305
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,18230,284,0.76 [0.57-1.01],0.061930487923555
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,16136,244,0.98 [0.65-1.46],0.9055513124528172
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,18887,296,0.99 [0.52-1.87],0.9665399539689415
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,18646,290,0.90 [0.73-1.11],0.3168024417743247
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,16189,244,1.04 [0.88-1.22],0.6542409007555947
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,15741,240,1.01 [0.90-1.12],0.9147294871672488
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",16161,245,1.10 [0.89-1.35],0.3682667041110027
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",16078,242,1.02 [0.91-1.14],0.7464326386132074
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,15662,238,1.03 [0.85-1.25],0.7793353944537852
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,15741,240,0.96 [0.71-1.29],0.7781615073252101
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,18504,291,0.88 [0.73-1.05],0.1585769641572977
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,15703,236,0.97 [0.84-1.12],0.6391242925283822
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,18653,291,0.89 [0.76-1.06],0.1842680498697063
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,18876,294,0.99 [0.89-1.10],0.824706351463505
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,16168,245,1.03 [0.85-1.24],0.770226333088512
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,15662,238,0.89 [0.66-1.21],0.4649034222252217
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,18340,284,1.02 [0.73-1.44],0.8963498090719504
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,16168,245,1.01 [0.88-1.17],0.8772553702535191
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,15700,238,0.89 [0.76-1.05],0.1582288331789762
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ELN,Elastin,16189,244,0.70 [0.48-1.00],0.0515410597514002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,18561,288,0.96 [0.78-1.17],0.6571461129307754
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,15662,238,1.10 [0.80-1.50],0.5545006196055253
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,18340,284,1.12 [0.90-1.38],0.318456075057373
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,14942,231,0.99 [0.79-1.24],0.9372323466517998
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,18887,296,1.65 [0.92-2.97],0.0922592356009205
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,18639,292,0.98 [0.86-1.12],0.7636753014504094
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,18821,295,0.96 [0.82-1.12],0.5945532796913866
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,15741,240,1.05 [0.86-1.28],0.6419819836285285
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,16130,242,0.86 [0.67-1.11],0.2507367619949442
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,15662,238,1.11 [0.71-1.72],0.6495584612508958
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,15662,238,0.52 [0.34-0.78],0.0017507910834964
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,18887,296,1.04 [0.68-1.59],0.8506491235403466
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,18710,288,1.17 [0.91-1.52],0.2220540139971388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,15741,240,0.98 [0.69-1.40],0.9262652985190544
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,18061,279,1.07 [0.94-1.21],0.336277580034953
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,16130,242,0.83 [0.64-1.06],0.136317690091551
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,18230,284,0.90 [0.70-1.15],0.4029740257022838
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,18323,284,1.09 [0.67-1.76],0.7328310437619647
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,18323,284,1.19 [0.81-1.77],0.3791456791688864
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,15741,240,0.92 [0.74-1.15],0.4577632333939894
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,15703,236,1.08 [0.73-1.61],0.7056760333073784
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,15777,238,0.95 [0.77-1.17],0.6033162995618746
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,18614,287,1.11 [0.99-1.23],0.06613331643507
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,16130,242,0.75 [0.53-1.07],0.1121234023007327
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,18674,286,1.22 [0.87-1.71],0.2519815901022554
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,18258,289,0.96 [0.81-1.13],0.6112093939269556
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,17995,274,1.15 [0.82-1.62],0.4202079784436356
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,15830,235,0.96 [0.62-1.47],0.8365096725136499
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,18887,296,1.38 [0.93-2.05],0.1071621238620348
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,18476,291,1.08 [0.78-1.48],0.6557274896420116
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,18323,284,0.95 [0.80-1.14],0.5934601393749601
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,15910,241,0.97 [0.73-1.30],0.8487186463407279
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,18646,290,1.11 [0.96-1.27],0.1470697508928526
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,15741,240,1.11 [0.93-1.31],0.2509708311047537
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,18802,294,1.36 [0.98-1.90],0.0684890698041296
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,18698,293,1.06 [0.69-1.63],0.8054596784683309
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,18556,286,1.20 [0.71-2.02],0.4979423106956203
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,18698,293,1.16 [0.75-1.80],0.5033871080864112
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,18561,288,1.00 [0.90-1.10],0.972653725489844
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,15777,238,1.01 [0.86-1.19],0.9017575095614532
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,15627,234,0.99 [0.69-1.43],0.9764636632130655
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,18476,291,0.97 [0.85-1.11],0.6637058555691402
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,15910,241,1.20 [0.85-1.70],0.3050492560403926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,15703,236,0.93 [0.70-1.23],0.6093494872962273
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,16130,242,1.34 [0.98-1.83],0.0707550491442914
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,15830,235,0.98 [0.88-1.09],0.6950346112896797
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,18535,288,1.04 [0.69-1.55],0.8593769925890644
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,15662,238,1.09 [0.82-1.45],0.5340431658293898
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,18887,296,0.97 [0.71-1.34],0.8699068262089951
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,18620,288,0.78 [0.58-1.07],0.1223757808519309
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,15627,234,1.03 [0.83-1.28],0.78907508769511
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,15703,236,0.95 [0.74-1.20],0.6503697658924683
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,16161,245,0.98 [0.85-1.14],0.8379934780564737
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,15627,234,0.70 [0.48-1.03],0.0716656973829818
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,15703,236,1.04 [0.90-1.20],0.5880094863346249
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,15910,241,0.81 [0.53-1.22],0.3054306576391843
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,15662,238,0.99 [0.78-1.24],0.9057335171466466
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,15662,238,0.93 [0.70-1.22],0.5815647828540779
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,18821,295,1.20 [0.78-1.83],0.4108865809347121
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,16208,243,1.09 [0.72-1.64],0.6938280361551599
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,15987,243,1.20 [0.84-1.71],0.3172885438626089
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,18654,292,0.93 [0.77-1.12],0.4492608966082168
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,16213,244,1.12 [0.83-1.52],0.4597776254283219
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,16145,244,1.05 [0.65-1.71],0.8312443533828292
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,16213,244,1.04 [0.46-2.33],0.9282901138418982
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,18689,288,1.06 [0.88-1.27],0.5374148231640383
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,18709,293,1.36 [0.91-2.02],0.1317353096470193
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,18716,294,1.14 [0.82-1.59],0.4382684885216567
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,18722,293,1.61 [0.92-2.81],0.0960752817559994
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",18620,288,1.02 [0.91-1.14],0.7291965914290152
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",18653,291,1.04 [0.92-1.18],0.5594008443597256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",16189,244,1.20 [0.96-1.49],0.1072863812120875
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",18887,296,1.07 [0.87-1.32],0.4945315556796228
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,18761,295,1.04 [0.89-1.21],0.6378912351882867
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,18293,284,1.19 [1.01-1.41],0.039954637471535
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,18646,290,1.00 [0.83-1.20],0.9827432343404904
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,18653,291,0.97 [0.84-1.11],0.6526269882626548
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,16136,244,0.97 [0.80-1.16],0.729658248596238
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,16168,245,1.06 [0.99-1.14],0.1176550958711971
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,16130,242,0.78 [0.47-1.29],0.3266095640613942
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,15741,240,0.96 [0.78-1.18],0.6947351519157209
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,16189,244,0.94 [0.60-1.46],0.7758842580123145
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,18561,288,1.14 [0.84-1.55],0.4147472323780472
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,18633,291,1.06 [0.75-1.50],0.7314377249796392
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,16136,244,1.11 [0.97-1.28],0.1304139664342665
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,18887,296,0.98 [0.67-1.43],0.9129157325847214
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,15777,238,1.09 [0.92-1.29],0.3366646315397494
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,18827,296,1.18 [0.90-1.55],0.2289719450547409
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,18876,294,1.02 [0.77-1.35],0.8822612732474612
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,16200,246,0.88 [0.59-1.31],0.5289502571649294
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,15777,238,1.02 [0.83-1.27],0.8366781674937873
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",18653,291,1.06 [0.92-1.22],0.3979219882474851
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,16189,244,1.03 [0.87-1.22],0.7384576290406044
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,18646,290,0.97 [0.78-1.20],0.7789496821049271
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,16168,245,1.34 [0.80-2.22],0.2629846266605375
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,18654,292,0.97 [0.79-1.20],0.7799606242321943
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,18598,292,0.99 [0.84-1.18],0.9188377553258378
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,18230,284,0.98 [0.82-1.19],0.8698172656479236
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,18689,294,0.99 [0.80-1.23],0.9417452491046556
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,16187,243,1.08 [0.86-1.35],0.5145562000275351
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,18592,289,1.16 [0.89-1.52],0.2678667277392355
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,18653,291,1.15 [0.91-1.45],0.2401535840537951
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,18790,292,1.09 [0.88-1.35],0.416596686247382
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,18340,284,1.15 [0.95-1.40],0.1571300517592041
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,18654,292,0.98 [0.82-1.18],0.8527170150961177
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,18646,290,1.08 [0.92-1.25],0.3425892940174482
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,18230,284,0.87 [0.73-1.05],0.1549527566253248
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",15662,238,0.90 [0.73-1.11],0.3302215847220331
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",15662,238,1.08 [0.88-1.34],0.4437596257965088
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,18230,284,0.93 [0.78-1.10],0.4109545679393488
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,18230,284,0.78 [0.61-1.00],0.0471686953551221
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,18722,293,1.05 [0.76-1.46],0.760806708041015
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,15847,242,1.23 [0.82-1.85],0.3102496102044864
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",16168,245,1.03 [0.89-1.20],0.6710874877270461
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,15703,236,1.15 [0.94-1.41],0.181841669544908
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,15703,236,0.95 [0.71-1.26],0.7225981258250536
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,18710,288,1.11 [0.97-1.27],0.1217574639036616
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,18646,290,0.95 [0.82-1.11],0.5504970949040151
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,15703,236,1.01 [0.76-1.33],0.9537854776390302
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,18806,293,1.00 [0.92-1.10],0.919411526748847
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,18800,294,1.01 [0.83-1.23],0.9072937905572696
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,15703,236,0.83 [0.52-1.30],0.4120833779093228
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,18340,284,1.29 [0.95-1.75],0.1055016557443323
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,15703,236,1.01 [0.73-1.39],0.9663544268591991
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,15627,234,0.88 [0.73-1.06],0.1656554721924677
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,15600,234,0.68 [0.50-0.92],0.0122385057484479
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,18698,293,0.94 [0.68-1.28],0.6775652759479344
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,16200,246,0.98 [0.77-1.24],0.8496394626808884
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,16161,245,1.04 [0.74-1.44],0.8353998946448387
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,18698,293,1.24 [0.78-1.98],0.3568435276483339
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,15830,235,0.94 [0.73-1.20],0.5981129356670454
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,16208,243,1.12 [0.93-1.36],0.2268707113329845
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,18258,289,0.90 [0.75-1.09],0.2901499664286128
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",15700,238,1.04 [0.90-1.20],0.6111826596785472
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,15662,238,0.96 [0.73-1.25],0.7423748945281617
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,18258,289,0.92 [0.79-1.06],0.2503717609521665
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,18616,286,1.00 [0.87-1.15],0.9709324893715536
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,16168,245,1.00 [0.88-1.13],0.9449199086446992
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,18722,291,0.95 [0.86-1.04],0.2459532023192817
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,18504,291,0.84 [0.66-1.08],0.1817198505186926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,18504,291,0.97 [0.87-1.08],0.6042045723790901
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,18230,289,0.95 [0.75-1.20],0.6495660916174449
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,16136,244,0.98 [0.80-1.21],0.8430878977124938
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,18230,284,1.00 [0.91-1.10],0.9809610485134974
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,18504,291,1.09 [0.76-1.57],0.6325409619439974
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,18524,288,0.73 [0.45-1.21],0.2251954851821183
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,18230,284,0.79 [0.55-1.14],0.2044593194788185
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,18876,294,1.07 [0.80-1.44],0.6496218844447079
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,18698,293,1.07 [0.79-1.45],0.6744170535733804
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,18258,289,0.93 [0.78-1.10],0.3887337888976279
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,18230,284,1.02 [0.75-1.37],0.9149132158991709
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,16213,244,1.11 [0.70-1.74],0.6600835980027386
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,16161,245,1.02 [0.79-1.32],0.8847791553909417
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,16130,242,1.02 [0.72-1.45],0.927107635571891
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,15703,236,0.98 [0.86-1.12],0.7715535880849878
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,18613,290,0.97 [0.68-1.38],0.8495084620011784
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,18821,295,1.33 [0.94-1.89],0.108771887748636
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,18640,291,1.03 [0.98-1.09],0.2428836930172199
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,15600,234,0.78 [0.55-1.11],0.172277838139476
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,18258,289,1.10 [0.84-1.42],0.4909489249353533
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,15703,236,1.18 [0.91-1.54],0.2123538833167933
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,18646,290,1.05 [0.93-1.18],0.4744261749324796
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,18230,284,1.02 [0.92-1.14],0.668085417020856
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,15662,238,1.02 [0.85-1.23],0.8143663408620695
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,15777,238,0.64 [0.45-0.90],0.0098183256928816
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,18447,290,0.70 [0.46-1.06],0.0879830764585796
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,15741,240,1.39 [1.11-1.73],0.0038844233675136
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FST,Follistatin,18689,288,0.83 [0.66-1.04],0.1032539280240445
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,15741,240,1.19 [0.68-2.09],0.5421689235363107
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,18589,287,1.06 [0.76-1.48],0.7215463056136241
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,16123,245,1.00 [0.87-1.16],0.9660588634409047
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,18757,295,0.90 [0.80-1.01],0.0824150840028959
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,15830,235,0.96 [0.78-1.18],0.7184780056495433
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FURIN,Furin,18698,293,1.07 [0.78-1.48],0.6620548449202233
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,18200,284,1.00 [0.76-1.31],0.9809160494847826
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",15882,240,1.26 [1.07-1.48],0.0057875899753852
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,18821,295,1.25 [1.00-1.56],0.04567231296984
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",18504,291,0.98 [0.82-1.17],0.7892159616907959
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",18830,294,0.92 [0.80-1.06],0.2610432709224963
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,18340,284,1.04 [0.89-1.23],0.6129095755347767
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,18616,292,0.98 [0.88-1.10],0.7673507283467463
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,15777,238,0.84 [0.65-1.08],0.1714238951686753
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,15700,238,0.97 [0.73-1.30],0.8423529838946056
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,16130,242,1.03 [0.79-1.33],0.8356943201711824
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,15910,241,1.04 [0.86-1.24],0.7055155243149358
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,15700,238,0.84 [0.67-1.06],0.1350498992845611
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,15627,234,0.97 [0.60-1.56],0.8904307887057289
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,15703,236,1.12 [0.88-1.42],0.3524748122808167
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,15910,241,0.98 [0.76-1.27],0.8978534164894005
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,15741,240,0.97 [0.76-1.23],0.7820135436779541
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,15627,234,1.04 [0.86-1.25],0.6840479773188421
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,18710,288,0.95 [0.81-1.11],0.5154869153967041
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,18561,288,1.15 [0.79-1.67],0.4767034081963844
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,18830,294,1.29 [0.88-1.90],0.1878902797376625
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,18340,284,0.89 [0.69-1.13],0.3334194092213867
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,16189,244,1.08 [0.71-1.66],0.7120981460930751
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,18561,288,1.91 [1.15-3.18],0.0130803988604627
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,15662,238,1.06 [0.74-1.52],0.7534337848248989
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,15483,230,0.73 [0.50-1.08],0.1126265404017649
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,16168,245,0.98 [0.61-1.58],0.9309669453736992
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,15910,241,0.88 [0.68-1.15],0.3446219193439073
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,18768,296,1.09 [0.72-1.66],0.6752351632771247
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,15662,238,0.96 [0.71-1.29],0.7798900429559436
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,16161,245,1.09 [1.00-1.18],0.0383267428883038
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,15627,234,0.95 [0.59-1.54],0.8438777333824304
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",15741,240,0.98 [0.83-1.15],0.7690624227463289
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,15777,238,0.82 [0.65-1.04],0.0977301629790024
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,16132,244,1.10 [0.91-1.33],0.3409136215793834
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,18340,284,1.03 [0.86-1.23],0.7621782557202482
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,18258,289,1.11 [0.90-1.36],0.3311632682097037
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,15662,238,0.94 [0.70-1.26],0.6869783956856418
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,16213,244,1.03 [0.64-1.65],0.8973168656866473
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,16161,245,0.99 [0.88-1.11],0.8446416607739687
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,18230,284,1.07 [0.99-1.16],0.1025555340739573
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,15449,228,0.93 [0.71-1.21],0.5734776806216451
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,15662,238,0.91 [0.68-1.23],0.5345040584277077
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",18561,288,0.96 [0.70-1.30],0.7827089634943128
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,18887,296,1.32 [1.07-1.63],0.0094766606588683
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,18653,291,1.11 [0.83-1.49],0.4835457526357858
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,18258,289,1.16 [0.89-1.52],0.2712271156708759
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,16189,244,1.09 [0.87-1.36],0.4385390744807732
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,18200,284,0.97 [0.77-1.22],0.7945033857706222
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,18230,284,1.08 [0.92-1.28],0.3426180778785117
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,18230,284,1.05 [0.97-1.14],0.1906410565293495
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,18806,293,1.43 [1.01-2.04],0.0465987756470189
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,18561,288,0.84 [0.50-1.39],0.4878216992899762
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,18448,291,1.01 [0.70-1.47],0.9493661743523244
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,15691,235,0.91 [0.74-1.13],0.3952872448753943
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,18258,289,0.86 [0.72-1.03],0.1068884759784084
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,16189,244,0.99 [0.83-1.17],0.8753703531155441
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,16161,243,0.96 [0.74-1.25],0.7619613578169798
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,18355,285,1.12 [0.82-1.51],0.480189109366296
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,18623,292,1.08 [0.88-1.33],0.4597765576672029
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,18504,291,0.97 [0.62-1.52],0.8971207565895646
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,18633,291,1.02 [0.97-1.09],0.4339221450582819
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,18230,284,1.03 [0.97-1.09],0.3865125958853339
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,15830,235,1.09 [0.69-1.71],0.711364488983306
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,18258,289,1.02 [0.84-1.23],0.8722726794492353
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,18653,291,1.03 [0.91-1.16],0.6454754059350407
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,16168,245,1.15 [0.84-1.56],0.3809388688819733
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,16168,245,1.06 [0.90-1.25],0.4922689807828947
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,15830,235,0.76 [0.49-1.17],0.2103379821263873
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,15627,234,1.09 [0.86-1.39],0.4736240578904661
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,15741,240,1.11 [0.90-1.38],0.3247722646443778
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,16161,245,1.32 [0.90-1.92],0.1534410381032809
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,16136,244,0.94 [0.83-1.06],0.3025508648935516
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,15703,236,1.08 [0.83-1.41],0.5549889307023106
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,15703,236,1.05 [0.92-1.19],0.4972632965004497
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,15627,234,0.84 [0.67-1.06],0.1404462084928132
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,17907,279,1.25 [0.86-1.82],0.2485851957263654
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,15803,235,1.09 [0.78-1.52],0.6148650495364396
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,18504,291,0.92 [0.72-1.17],0.4895842135611704
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,15703,236,1.13 [0.78-1.65],0.5212715045272955
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,18323,284,1.08 [0.90-1.29],0.4248757705601075
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,18595,286,0.87 [0.64-1.19],0.3843836687478668
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,15700,238,1.05 [0.75-1.45],0.7841851486513406
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,18531,289,0.84 [0.70-1.01],0.0665360753735809
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",15830,235,0.95 [0.82-1.10],0.4769058248515089
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,18258,289,0.91 [0.71-1.17],0.457675636466428
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,16130,242,0.80 [0.62-1.03],0.0791300313092294
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,15807,239,0.98 [0.69-1.38],0.901635771043209
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,16189,244,0.96 [0.81-1.14],0.6197929529498394
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,18876,294,0.85 [0.69-1.04],0.1150736699512759
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,15830,235,0.92 [0.76-1.12],0.4213571288301184
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,16168,245,1.10 [0.96-1.26],0.1554501238104928
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,18230,284,0.95 [0.81-1.12],0.550124874036086
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,15777,238,0.94 [0.72-1.22],0.6231205062042326
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,18654,292,1.19 [0.99-1.44],0.067375627883476
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,15741,240,0.89 [0.60-1.33],0.5798654971383534
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,15830,235,0.85 [0.60-1.20],0.3583390756731097
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,16168,245,1.03 [0.88-1.20],0.7541040190928933
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,18821,295,1.70 [1.16-2.50],0.0060351583308706
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,18646,290,1.01 [0.91-1.12],0.8737403483808406
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,16136,244,1.10 [0.85-1.43],0.4520538403517655
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",16200,246,1.10 [0.83-1.47],0.4977657314599298
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,18601,290,1.05 [0.77-1.44],0.7530837833738797
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,15662,238,1.09 [0.91-1.31],0.3499331796093893
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,18088,280,1.03 [0.91-1.17],0.6333633066245499
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,15830,235,0.92 [0.65-1.30],0.6479143941499325
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,18616,292,0.97 [0.86-1.09],0.5705025756915064
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,18561,288,1.06 [0.99-1.15],0.1112233707720409
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,18830,294,1.13 [0.79-1.60],0.4988772901118126
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,18504,291,1.00 [0.83-1.20],0.9945212009889408
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,16130,242,1.10 [0.87-1.38],0.4448173050091045
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,16136,244,0.96 [0.72-1.29],0.7925671705947801
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,16208,243,1.02 [0.78-1.33],0.8861503489698533
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,16136,244,1.00 [0.85-1.18],0.9823896191810728
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,18258,289,0.81 [0.55-1.19],0.2796355883561657
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,18159,284,0.87 [0.61-1.26],0.4616249388745926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,15700,238,1.08 [0.88-1.32],0.4807210727959139
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,16168,245,0.92 [0.63-1.33],0.6496446338341002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,16136,244,0.97 [0.79-1.19],0.7744069578664784
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,18323,284,1.00 [0.85-1.18],0.9745094834425532
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,16130,242,0.99 [0.79-1.25],0.9577555670497384
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,18653,291,1.00 [0.93-1.09],0.905507854054184
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,16189,244,0.97 [0.80-1.18],0.7558125394383582
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",16168,245,0.79 [0.58-1.08],0.1401715930755684
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",15700,238,1.04 [0.83-1.30],0.7271922074849004
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,18323,284,0.95 [0.76-1.18],0.6401531667305439
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,18555,292,1.50 [0.98-2.29],0.0613391816297391
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,15741,240,0.97 [0.77-1.22],0.77231968695602
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",18561,288,0.95 [0.78-1.14],0.5575797395441304
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,15539,233,0.98 [0.84-1.15],0.8049243344091903
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,18230,284,1.05 [0.93-1.18],0.4118140271182313
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,16139,242,0.94 [0.48-1.83],0.8540616847712982
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",16123,242,1.03 [0.59-1.81],0.9139595363347988
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,18623,290,1.05 [0.93-1.19],0.4130398053167875
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,18230,284,1.04 [0.91-1.20],0.5757685427202437
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,15662,238,0.93 [0.78-1.12],0.4380932101749618
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,18142,286,1.09 [0.94-1.26],0.2695582889003847
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,16161,245,0.99 [0.95-1.05],0.8395611953486518
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,15910,241,1.07 [0.91-1.27],0.426388972994518
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,15777,238,1.01 [0.86-1.18],0.9277751562016568
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,18553,292,1.14 [0.85-1.54],0.3791744288058275
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,15910,241,1.04 [0.89-1.21],0.627154404101048
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,15662,238,0.97 [0.70-1.34],0.8383965590909566
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,18734,295,1.05 [0.89-1.23],0.5773184584275851
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",18323,284,1.06 [0.94-1.19],0.3369775688891541
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,18876,294,1.25 [0.92-1.69],0.1523712997665118
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,18646,290,1.02 [0.87-1.19],0.7939054117441358
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,18323,284,1.02 [0.89-1.17],0.7370572824038462
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,15627,234,1.02 [0.79-1.30],0.8994718078246933
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",15662,238,1.04 [0.87-1.23],0.6833485726648627
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",18780,293,0.91 [0.79-1.05],0.2085754690507132
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,18830,294,1.03 [0.94-1.12],0.5304451989180039
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",18654,292,0.98 [0.85-1.12],0.7468039426830058
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,18804,294,1.25 [1.07-1.46],0.0057128448909561
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,18654,292,1.03 [0.77-1.38],0.8548952821863323
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,18780,293,0.97 [0.84-1.12],0.6845077984873139
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,18830,294,0.90 [0.76-1.06],0.2145664192755337
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,16189,244,1.03 [0.92-1.16],0.5785466789892987
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,15662,238,0.91 [0.70-1.18],0.4741694747133342
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,18876,294,0.95 [0.79-1.14],0.5714233704964738
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,15703,236,0.97 [0.78-1.21],0.8201949759045719
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,15700,238,0.88 [0.71-1.09],0.2376121633203161
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,16136,244,0.92 [0.69-1.22],0.5698024316209749
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,18795,294,1.04 [0.93-1.16],0.5068122180591833
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,16161,245,0.99 [0.82-1.20],0.9235076271978868
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,18323,284,1.11 [0.92-1.34],0.2935597388451321
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,15830,235,1.17 [0.74-1.86],0.4947969231854684
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,16161,245,0.89 [0.67-1.18],0.4316126391896201
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,16189,244,1.08 [0.70-1.66],0.7419964003043322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,18646,290,0.99 [0.87-1.13],0.8852857676165604
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,18876,294,1.07 [0.79-1.44],0.6725367275139206
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,16066,241,0.70 [0.45-1.10],0.1220667909673365
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,18230,284,0.98 [0.85-1.12],0.7455315776585314
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,16161,245,1.04 [0.88-1.22],0.6604043269612652
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,15703,236,1.27 [1.08-1.48],0.0029755678175025
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,15662,238,0.82 [0.55-1.23],0.3479257787086316
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,16126,245,1.18 [0.94-1.49],0.1522311465604481
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,16168,245,1.04 [0.78-1.38],0.7874356682792725
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,18323,284,0.96 [0.65-1.41],0.8324433918824462
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",16168,245,1.02 [0.70-1.47],0.9276895259905676
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",18583,289,1.09 [0.82-1.45],0.5554415786912285
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",18646,290,0.94 [0.66-1.36],0.7586083467409177
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,18830,294,0.74 [0.58-0.94],0.0159255769902949
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,15800,235,0.99 [0.79-1.23],0.8955854666399892
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",15741,240,0.96 [0.74-1.25],0.7700364098496678
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",15662,238,1.06 [0.80-1.39],0.7009894815916125
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,15589,234,1.32 [1.08-1.62],0.005914538941452
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,18456,291,0.80 [0.64-0.99],0.0381646997857616
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,18258,289,0.91 [0.71-1.16],0.4326153865528431
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,15777,238,0.99 [0.83-1.19],0.94430156673119
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,18420,291,0.94 [0.75-1.17],0.5606409934689767
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,18258,284,1.01 [0.88-1.16],0.8604260820824716
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,16168,245,1.01 [0.80-1.29],0.91206067528164
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,18876,294,0.97 [0.84-1.11],0.6272563924148368
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,18230,284,0.96 [0.72-1.27],0.7690779541851417
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,16003,243,0.99 [0.87-1.13],0.8887210524038718
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,15881,241,0.92 [0.80-1.07],0.2778739586601271
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,15741,240,1.10 [0.75-1.62],0.6336272197397701
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,16145,244,1.23 [0.84-1.80],0.2979900073890535
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,15741,240,0.99 [0.86-1.13],0.8451989645903304
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,18561,288,1.10 [0.83-1.46],0.5011540611620776
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,18830,294,1.19 [0.91-1.54],0.202865696545419
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,15703,236,1.39 [1.01-1.91],0.0462200325705115
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,15741,240,1.01 [0.89-1.15],0.8852116227252984
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,18646,290,0.97 [0.74-1.25],0.7899045257757601
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,16161,245,0.97 [0.80-1.19],0.7945444043198011
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,15662,238,1.04 [0.81-1.33],0.754063211387388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,15741,240,0.85 [0.65-1.11],0.2305857878971694
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,18173,287,1.01 [0.86-1.18],0.9366405507223972
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,18674,286,1.01 [0.87-1.17],0.9353444571030344
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,16130,242,1.17 [0.83-1.64],0.3763278514890431
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,18362,289,0.93 [0.80-1.07],0.3170025989248494
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,18830,294,1.23 [0.96-1.58],0.0998144660971462
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,18540,289,1.01 [0.68-1.48],0.979189514788778
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,15700,238,1.08 [0.92-1.27],0.3424141715278352
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,15700,238,0.91 [0.68-1.22],0.5340497734241838
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",18698,293,1.04 [0.88-1.24],0.6184246863225518
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,18579,290,1.04 [0.66-1.65],0.8525619422295683
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,18887,296,1.24 [0.80-1.92],0.3416058290134259
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,18340,284,1.03 [0.90-1.18],0.6457069299010427
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,18597,291,0.97 [0.67-1.40],0.8828831366262954
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,18887,296,1.19 [0.87-1.63],0.2731709483778363
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,18887,296,1.23 [0.83-1.83],0.2957148691710921
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,18646,290,0.80 [0.66-0.98],0.0280471072725883
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,18653,291,1.11 [0.88-1.39],0.3754240627107854
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,18561,288,1.12 [0.65-1.94],0.6830123756383117
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,15910,241,1.05 [0.80-1.38],0.6996691277899115
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,18258,289,0.95 [0.76-1.17],0.6207774652183975
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",15741,240,1.07 [0.87-1.30],0.5346128382261068
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,18876,294,1.49 [0.46-4.86],0.5073893317909668
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,18830,294,0.89 [0.71-1.10],0.2788922924086713
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,15771,241,1.28 [0.94-1.75],0.1216140197290655
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,15910,241,0.99 [0.78-1.26],0.9377992620634332
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,15910,241,1.03 [0.74-1.43],0.8701086630879505
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,16136,244,0.82 [0.50-1.35],0.4369637858421169
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,18340,284,0.98 [0.89-1.08],0.6517724160190317
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,18710,288,0.96 [0.59-1.57],0.8742090529802059
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,18504,291,0.91 [0.75-1.12],0.3831132597090825
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,18258,289,0.91 [0.72-1.15],0.4185682451675758
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,15700,238,1.03 [0.84-1.25],0.7932085008711679
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,18646,290,1.16 [0.87-1.55],0.3134139282134
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,15662,238,0.73 [0.48-1.11],0.142356451294738
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,15777,238,0.84 [0.62-1.14],0.2600010459595446
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,16168,245,0.92 [0.75-1.13],0.4531278911072002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,15700,238,1.00 [0.77-1.29],0.9811562894349404
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,16200,246,1.03 [0.65-1.61],0.912605885309929
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,18561,288,1.11 [0.68-1.79],0.6774601732068792
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,15662,238,1.00 [0.76-1.32],0.998282664983239
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,18654,292,1.18 [0.76-1.82],0.4624501754003253
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,18862,296,0.91 [0.84-0.99],0.0278320841939804
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,18857,296,1.09 [0.91-1.29],0.3431648720969334
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,18745,294,1.01 [0.74-1.38],0.9565501704619512
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,18429,290,1.10 [0.88-1.39],0.3984341858810566
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,18595,292,1.23 [0.90-1.70],0.1950086551929666
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,18887,296,1.41 [1.05-1.89],0.0231982283467806
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,18653,291,1.04 [0.76-1.42],0.7919132614622768
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,15703,236,1.08 [0.93-1.26],0.3038007296289586
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,15662,238,0.97 [0.78-1.22],0.80231607038405
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,16191,244,1.01 [0.62-1.65],0.9608252197939688
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,15627,234,0.91 [0.77-1.06],0.2332518961989002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,15741,240,0.85 [0.61-1.19],0.3392456730841593
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,18561,288,1.32 [0.98-1.78],0.0683040742704735
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,18653,291,1.10 [0.79-1.54],0.5761504023086512
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,16189,244,1.02 [0.88-1.18],0.80918976561129
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,18646,290,1.04 [0.92-1.16],0.5354711945129813
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,18230,284,1.03 [0.92-1.16],0.578573487090227
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,18340,284,0.99 [0.87-1.14],0.9094784551808002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,18340,284,0.86 [0.69-1.06],0.1576382590663225
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,18710,288,1.18 [0.83-1.67],0.3668639763925544
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,18340,284,0.99 [0.83-1.18],0.8789090577825573
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,18561,288,1.03 [0.89-1.18],0.7149460854816865
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,18876,294,1.08 [0.89-1.30],0.4534376290156094
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,18340,284,1.03 [0.78-1.37],0.8397941818741194
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,15703,236,0.86 [0.62-1.20],0.3776691923180686
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,18340,284,1.00 [0.81-1.23],0.9809726899324142
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,18410,289,1.34 [0.86-2.08],0.1910099316466146
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,15700,238,0.93 [0.61-1.42],0.7381847291270291
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,18646,290,0.82 [0.59-1.12],0.2159896186020499
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,18340,284,0.90 [0.66-1.21],0.4839390479080223
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,18876,294,0.85 [0.66-1.09],0.1984662967491552
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,18300,284,0.97 [0.75-1.24],0.7945744774077617
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,18340,284,0.98 [0.85-1.14],0.8007731180104538
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,18340,284,1.06 [0.80-1.41],0.6631869487293321
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,18340,284,1.03 [0.89-1.18],0.7278124964964221
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,18654,292,1.04 [0.83-1.32],0.714331161752485
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,18417,284,1.11 [0.91-1.35],0.3062278542480946
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,18555,286,0.85 [0.66-1.08],0.1758649869980671
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,18745,294,1.11 [0.80-1.55],0.5281882524671866
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,18876,294,1.46 [1.07-1.99],0.017454612092888
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,18388,288,0.99 [0.93-1.05],0.730250799635835
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,18182,281,1.04 [0.90-1.20],0.6189534542500856
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,18340,284,1.05 [0.89-1.23],0.5690930077525613
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,18254,283,1.01 [0.84-1.22],0.9300873174586812
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,18623,292,1.29 [0.83-2.00],0.2636007249501055
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,18591,288,1.14 [0.67-1.92],0.6311958132013926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,18654,292,1.22 [0.98-1.52],0.0701129808181986
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,18827,296,1.05 [0.84-1.31],0.6851002102520825
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,18340,284,0.93 [0.70-1.23],0.6103038293113378
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,18587,286,1.02 [0.83-1.24],0.8673373378306102
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,18340,284,0.81 [0.58-1.13],0.2173029446898312
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,18340,284,1.00 [0.80-1.25],0.9903566765993944
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,18340,284,0.91 [0.70-1.19],0.4877110386482119
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,15703,236,0.96 [0.71-1.30],0.7974864632234631
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,15703,236,1.07 [0.87-1.31],0.5347072402931299
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,16130,242,1.10 [0.93-1.31],0.2724033450434709
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,18340,284,1.17 [0.96-1.43],0.1159586443083795
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,18340,284,0.90 [0.72-1.13],0.3828642047666065
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,15569,234,0.99 [0.69-1.44],0.9679453090655716
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,18537,291,1.04 [0.81-1.36],0.740332460730958
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,18340,284,1.10 [0.84-1.45],0.4780459285260399
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,16130,242,1.14 [0.82-1.57],0.4334294997880856
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,15627,234,0.94 [0.78-1.14],0.5447503191176231
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,15703,236,1.14 [0.93-1.39],0.2090305295957782
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,15646,235,1.07 [0.76-1.50],0.7113102672282585
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,18646,290,0.94 [0.73-1.20],0.611059967633408
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,18340,284,0.91 [0.70-1.19],0.5121790434131437
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,18226,287,0.91 [0.68-1.22],0.5235359044112289
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,15703,236,1.01 [0.81-1.24],0.9616200356556855
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,15657,235,0.92 [0.75-1.12],0.4092863960026427
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,18340,284,1.12 [0.81-1.56],0.4958844482888476
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,18340,284,0.94 [0.85-1.04],0.2589173083189757
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,18646,290,1.09 [0.82-1.46],0.5526772759891934
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,18340,284,0.99 [0.92-1.07],0.8843712586075257
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,18646,290,0.88 [0.73-1.06],0.1789995788806737
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,18561,288,0.98 [0.85-1.12],0.7524210812469377
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,18571,290,1.01 [0.75-1.36],0.9539982929982388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,18653,291,1.50 [0.83-2.72],0.1767321882493808
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,18646,290,1.00 [0.85-1.17],0.9691699043119442
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,18654,292,1.00 [0.82-1.21],0.9701070050686772
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,15910,241,0.95 [0.75-1.20],0.6417856775432036
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,18227,289,1.02 [0.85-1.22],0.862541534945243
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,16130,242,1.06 [0.81-1.39],0.6855401257318494
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,18504,291,0.99 [0.83-1.18],0.9168223446522143
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,16161,245,0.98 [0.78-1.23],0.870631229498964
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,15700,238,0.84 [0.55-1.30],0.4420584553004861
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,18230,289,1.01 [0.81-1.25],0.9579818524633792
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,15830,235,0.99 [0.78-1.26],0.9340362350617034
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,18654,292,1.07 [0.82-1.39],0.6318749863503905
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,18561,288,1.01 [0.83-1.23],0.9232055533047988
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",15741,240,0.99 [0.80-1.24],0.9470551766259012
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",16168,245,1.00 [0.74-1.35],0.998428731091766
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",18561,288,1.02 [0.91-1.13],0.750184190317206
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,16161,245,1.02 [0.89-1.16],0.7901891280692572
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,16130,242,0.97 [0.75-1.26],0.8047601639823274
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,16136,244,1.05 [0.93-1.19],0.4041383980573754
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,15703,236,1.27 [0.60-2.69],0.5245995053790518
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,18470,291,1.02 [0.91-1.15],0.6934356507324402
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,18561,288,1.12 [0.92-1.35],0.2591496776430845
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",18323,284,1.00 [0.88-1.13],0.9674336611141604
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,18340,284,1.03 [0.89-1.21],0.6647254260442224
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,18646,290,0.99 [0.89-1.09],0.8065135717296696
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,17978,283,0.95 [0.72-1.24],0.6875161353780416
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,18646,290,0.96 [0.73-1.25],0.7499935271216243
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,16200,246,1.03 [0.77-1.36],0.8571461289582464
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,16010,244,0.97 [0.86-1.10],0.6370969658502377
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,18646,290,0.77 [0.57-1.05],0.0987208350226351
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,15830,235,1.07 [0.74-1.54],0.7148747188710153
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,18654,292,1.36 [0.90-2.07],0.1488583628223766
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,18646,290,1.02 [0.84-1.25],0.8199910818687597
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,15703,236,1.27 [0.94-1.72],0.1147469858121958
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,18654,292,1.08 [0.78-1.50],0.6480968034882186
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,18830,294,0.92 [0.50-1.72],0.8041025669634083
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,15910,241,1.09 [0.87-1.37],0.4626826147267382
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,18660,294,1.02 [0.62-1.69],0.9247733160915004
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,18230,284,1.06 [0.81-1.38],0.6883383820867457
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,18323,284,0.97 [0.88-1.07],0.5292986352508815
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,18567,294,1.19 [0.82-1.72],0.360783031360403
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,18698,293,0.87 [0.66-1.16],0.3468418326979754
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,18340,284,0.95 [0.67-1.34],0.7631740446761377
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,18830,294,1.13 [0.91-1.41],0.2674956329580011
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,16200,246,1.29 [0.94-1.76],0.1144122088884657
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,16213,244,1.12 [0.58-2.17],0.7295453303756326
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,18745,294,1.22 [0.93-1.60],0.1613329371941491
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,16213,244,1.10 [0.66-1.82],0.7145059870494601
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,16130,242,0.87 [0.65-1.17],0.3626511394668988
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,18646,290,0.93 [0.79-1.10],0.4090089601021601
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,15662,238,0.99 [0.82-1.19],0.8978403423071957
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",15741,240,0.97 [0.81-1.17],0.7618280224921453
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",15700,238,0.79 [0.58-1.08],0.1418201757703248
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",18258,289,1.08 [0.89-1.31],0.4510715101192637
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,15627,234,1.11 [0.87-1.42],0.4013244259480425
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,18821,295,1.30 [0.90-1.89],0.1663214525415852
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,15830,235,0.94 [0.73-1.21],0.6247790926559359
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,18340,284,1.02 [0.86-1.22],0.7861155639933611
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,15627,234,0.99 [0.79-1.23],0.9253043497096656
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,16136,244,0.97 [0.84-1.12],0.6793571045573452
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,18340,284,1.00 [0.80-1.25],0.988364801958626
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,18561,288,0.99 [0.79-1.25],0.9606869112396136
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,16136,244,1.01 [0.90-1.14],0.8465137134526763
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,15700,238,1.04 [0.82-1.30],0.7667875944318475
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,15777,238,1.00 [0.85-1.18],0.9804793683313694
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,18258,289,1.06 [0.87-1.29],0.5948450635191356
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,15845,243,1.23 [0.96-1.57],0.1013817487750723
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,15703,236,0.98 [0.85-1.14],0.8337006998804806
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,18698,293,1.47 [0.98-2.22],0.0648936077291814
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,18258,289,0.92 [0.69-1.23],0.5751236703068807
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,15627,234,0.96 [0.80-1.17],0.6980158284296603
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,15741,240,0.95 [0.77-1.15],0.5795976558562741
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,16161,245,0.77 [0.51-1.16],0.2151271580325431
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,15910,241,0.99 [0.83-1.18],0.9161217395511294
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,15910,241,0.72 [0.45-1.15],0.1678073753996045
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,16130,242,1.21 [1.01-1.46],0.0394857617454805
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,15662,238,0.90 [0.61-1.34],0.6057860197097451
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,15700,238,1.05 [0.89-1.23],0.5590322012887394
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,15662,238,1.01 [0.91-1.11],0.9042234204228842
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,18561,288,0.98 [0.86-1.11],0.7319147827602999
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,16130,242,1.15 [1.00-1.31],0.0444148287322651
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,18230,284,1.12 [0.98-1.28],0.0846322023109103
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,16136,244,1.01 [0.94-1.09],0.723484721537308
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,18230,284,0.97 [0.89-1.06],0.5166433620554016
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,15627,234,0.87 [0.72-1.04],0.119772799403891
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,15700,238,0.90 [0.70-1.15],0.4005791138040759
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,18258,289,1.04 [0.81-1.34],0.7497700290390283
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,18722,293,0.99 [0.70-1.40],0.9519406351471352
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,18653,291,0.95 [0.72-1.25],0.7047146427630155
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,18258,289,1.08 [0.94-1.24],0.2838382000085048
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,15700,238,0.84 [0.61-1.15],0.2653048545250462
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,16168,245,1.11 [0.88-1.40],0.39244995200877
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,18481,292,0.99 [0.91-1.07],0.7534131156409329
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,18645,293,0.91 [0.71-1.18],0.4807672239354543
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,18512,291,1.01 [0.73-1.39],0.9627103536201064
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,18230,284,1.00 [0.92-1.08],0.9951708366909846
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,18222,286,0.98 [0.77-1.23],0.842890267542524
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,18830,294,0.91 [0.73-1.14],0.4188527900202105
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,16098,241,0.93 [0.73-1.17],0.530199324044295
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,16200,246,1.15 [1.04-1.28],0.0087895140998238
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,18830,294,1.16 [1.00-1.35],0.0515373462410724
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,18661,293,0.89 [0.64-1.24],0.4922485253739658
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,15444,229,1.02 [0.73-1.43],0.916289595115202
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,18022,282,1.17 [0.88-1.55],0.2921711248301408
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,15897,243,1.03 [0.62-1.72],0.9035388942121764
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,18876,294,1.41 [1.09-1.83],0.0093216141401652
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,15700,238,1.05 [0.86-1.28],0.6571212895217313
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,18876,294,1.39 [1.12-1.72],0.0029694005832008
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,15703,236,1.30 [1.04-1.63],0.0218629470092209
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,16161,245,1.12 [0.86-1.44],0.4070488498517624
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",17702,283,1.07 [0.76-1.51],0.694769006705064
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",15662,238,1.04 [0.76-1.43],0.8022255691481204
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",18561,288,1.11 [0.99-1.26],0.0830676145996681
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",18615,290,1.19 [1.03-1.38],0.0196398648380817
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",18258,289,0.92 [0.75-1.13],0.4227069094664036
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",15662,238,0.67 [0.45-1.00],0.0503101967064385
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",15700,238,1.10 [0.96-1.26],0.166992256694307
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,18622,291,0.89 [0.74-1.08],0.2409927544889195
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,18876,294,1.05 [0.83-1.32],0.6853066788131288
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,18698,293,1.17 [0.82-1.66],0.3875273718909429
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,16189,244,0.99 [0.86-1.13],0.869095186912755
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,16096,242,0.82 [0.60-1.11],0.2015604326362408
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,18653,291,0.99 [0.84-1.16],0.9091057055605476
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,18561,288,0.96 [0.73-1.25],0.7447526356627391
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,18620,288,0.95 [0.72-1.27],0.743865830389203
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,18504,291,1.00 [0.90-1.10],0.9479475331982292
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,15662,238,0.85 [0.65-1.13],0.2687495664944657
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,18710,288,0.86 [0.63-1.17],0.3314140103193106
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,15741,240,0.90 [0.60-1.34],0.5912319910973858
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,15760,236,1.10 [0.68-1.78],0.7000378353530133
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,18094,287,1.77 [1.06-2.96],0.0304426194099366
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,18842,293,1.01 [0.84-1.23],0.8864881372352511
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,16130,242,0.94 [0.68-1.29],0.6847068767051634
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,18340,284,0.88 [0.70-1.10],0.2657097784067987
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,16130,242,1.02 [0.84-1.23],0.8670711191576727
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,18876,294,1.00 [0.87-1.14],0.973279217043348
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,18561,288,1.06 [0.98-1.15],0.1382317787768215
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,15703,236,1.06 [0.91-1.23],0.447281805643236
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,18476,291,1.06 [0.79-1.43],0.6942257649865224
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,18745,294,1.06 [0.89-1.26],0.5144443104985478
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,18821,295,0.89 [0.76-1.05],0.15673018261807
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,16208,243,1.11 [0.63-1.95],0.722659842807565
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,16168,245,1.00 [0.82-1.23],0.992630473996073
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,18120,282,0.81 [0.61-1.07],0.1390815786759766
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,16200,246,0.96 [0.74-1.25],0.7741490895907267
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,18703,294,0.98 [0.80-1.21],0.8619309104270576
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,16168,245,1.05 [0.92-1.18],0.4739067619183982
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,16189,244,0.95 [0.79-1.15],0.6227276485783921
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,18806,293,0.89 [0.73-1.09],0.2696417552000489
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,15280,224,1.09 [0.91-1.32],0.3441297434425323
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,15700,238,0.82 [0.67-1.00],0.0492766126631089
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,16168,245,1.08 [0.76-1.55],0.6678391064461302
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LEP,Leptin,18653,291,0.99 [0.85-1.15],0.8486269473606682
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,18653,291,0.92 [0.66-1.28],0.6113829984127626
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,16168,245,1.02 [0.81-1.28],0.8632789702831527
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,18653,291,1.12 [0.83-1.50],0.4688541265674582
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,18713,296,1.03 [0.73-1.46],0.8499649581723507
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,16213,244,1.25 [0.86-1.80],0.2435302712360365
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,18620,288,1.30 [1.09-1.55],0.0028493250442769
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,18623,290,0.96 [0.75-1.23],0.7466060153483814
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,18821,295,1.03 [0.87-1.22],0.7591879082588939
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,18631,288,0.99 [0.70-1.40],0.9393442804776584
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,18710,288,1.21 [0.91-1.61],0.186890317130141
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,18230,284,0.94 [0.83-1.06],0.2960394250893782
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,18645,286,0.89 [0.75-1.06],0.2075869103209704
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,18258,289,1.08 [0.89-1.31],0.4390860819001041
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,18646,290,0.98 [0.63-1.52],0.9161295672103388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,18654,292,1.09 [0.81-1.46],0.5676418034012292
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,16200,246,1.06 [0.96-1.17],0.2458939793183042
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,15662,238,0.98 [0.76-1.25],0.8483511519742283
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,18633,291,1.22 [0.89-1.68],0.2248994319800865
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,16189,244,0.88 [0.75-1.04],0.1283268685874246
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,18887,296,1.14 [0.78-1.66],0.5067862969564121
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,18797,296,0.94 [0.70-1.26],0.6642983394658624
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,18340,284,0.96 [0.75-1.22],0.7357092618502096
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,18887,296,1.01 [0.87-1.16],0.9366333117740916
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,15741,240,1.05 [0.86-1.28],0.6211298085586164
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,16109,244,0.95 [0.78-1.16],0.6444383544786322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,16161,245,1.22 [0.79-1.86],0.3687531396805246
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,16168,245,0.88 [0.61-1.29],0.5245420705933924
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,15700,238,0.95 [0.77-1.18],0.6585353395541899
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",15741,240,0.95 [0.82-1.10],0.5089257821155634
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),15859,242,1.00 [0.94-1.07],0.9522336163316588
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,18561,288,0.97 [0.75-1.24],0.7859628693894906
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,18653,291,0.84 [0.68-1.04],0.1065132057852736
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,18006,284,1.18 [0.99-1.40],0.0700470993758628
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,15662,238,1.14 [0.94-1.38],0.184227170431046
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,15662,238,1.03 [0.85-1.24],0.7739605282824392
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,15777,238,1.14 [0.88-1.47],0.3342458832797178
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,16213,244,1.78 [1.13-2.80],0.0130405168439066
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,18780,293,1.10 [0.82-1.47],0.5239959703914914
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,15654,235,0.98 [0.61-1.56],0.9198297211229204
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,18561,288,0.96 [0.65-1.42],0.8427592206350204
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,18653,291,1.10 [0.83-1.45],0.5189507827965527
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,15777,238,0.88 [0.62-1.27],0.5055618186558564
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,15777,238,0.88 [0.74-1.05],0.1679037451101651
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,18821,295,1.06 [0.89-1.26],0.5396871331302351
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,18561,288,1.10 [0.84-1.42],0.4961166188203311
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,16136,244,1.17 [0.89-1.55],0.2587022206781722
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,15777,238,1.00 [0.78-1.30],0.9702093046142066
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,16189,244,1.02 [0.79-1.32],0.8681433364982893
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,16130,242,0.98 [0.76-1.27],0.8707396615888836
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,18340,284,0.85 [0.66-1.11],0.2397113883001221
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,15777,238,0.80 [0.58-1.12],0.1924661914816264
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,16168,245,0.83 [0.51-1.36],0.4592990048417176
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,18230,284,0.99 [0.82-1.20],0.934005198525568
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,15910,241,1.16 [1.01-1.32],0.0290444255841266
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,18646,290,0.89 [0.69-1.16],0.3976230972931881
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,18646,290,0.85 [0.65-1.11],0.231858093235166
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,18830,294,1.06 [0.89-1.25],0.5361898794048721
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,16130,242,1.13 [0.83-1.54],0.4441164292631259
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,18887,296,1.14 [0.81-1.59],0.4567090818212229
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,18230,284,1.17 [0.97-1.41],0.1019367926153777
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,18526,286,1.16 [0.81-1.65],0.4195102928007238
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,18340,284,1.06 [0.82-1.36],0.674092490965313
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,16130,242,1.04 [0.79-1.38],0.7669797762148459
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LXN,Latexin,18420,290,0.93 [0.80-1.09],0.3676332820563902
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,18532,286,0.97 [0.73-1.28],0.8226790933506224
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,18646,290,1.21 [0.92-1.59],0.170777674868463
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,18422,288,1.42 [0.99-2.04],0.0539896277405469
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,18504,291,0.95 [0.71-1.27],0.7450512902162081
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,18230,284,0.88 [0.70-1.09],0.2413568203144224
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,18561,288,1.02 [0.91-1.16],0.7126554060113948
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,18258,289,1.01 [0.86-1.18],0.9446102949672994
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,18556,291,0.95 [0.70-1.30],0.7526383280545106
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,18230,284,0.83 [0.66-1.04],0.102651879377357
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,15700,238,0.90 [0.79-1.03],0.1306267154379813
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,15777,238,1.00 [0.89-1.13],0.9911043743306798
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,16213,244,1.36 [0.73-2.53],0.3376924920183278
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,15627,234,0.72 [0.50-1.05],0.0846122866431116
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,15830,235,1.04 [0.87-1.25],0.6356453302783903
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,15741,240,1.13 [0.83-1.53],0.4449906423264967
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,18447,291,0.99 [0.80-1.22],0.9237952471192248
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,18230,284,0.87 [0.65-1.17],0.3590790331995664
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,15777,238,0.94 [0.73-1.21],0.6280739917078728
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,15910,241,0.94 [0.82-1.07],0.3345121608065825
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,18230,284,1.04 [0.83-1.29],0.7602990248230749
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,16189,244,1.03 [0.73-1.45],0.8815812925847104
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,16130,242,1.04 [0.84-1.29],0.7034062000418275
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",15741,240,1.32 [0.80-2.17],0.2737334967784668
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,16189,244,0.96 [0.79-1.18],0.7120307741668289
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",15627,234,0.94 [0.73-1.21],0.6268503375935839
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,18710,288,0.97 [0.90-1.06],0.5351112778550575
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,18698,293,1.03 [0.71-1.50],0.8630713865885672
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,15662,238,1.05 [0.88-1.25],0.5806469649045076
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,15700,238,1.09 [0.73-1.61],0.6781955955441286
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,15662,238,1.08 [0.91-1.27],0.3967186271332334
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,16161,245,1.15 [0.89-1.48],0.2813198144469987
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,16136,244,1.04 [0.86-1.26],0.6992151618109324
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,18646,290,1.01 [0.91-1.12],0.837401976371856
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,18230,284,1.01 [0.91-1.13],0.8579296052470666
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,18476,291,1.00 [0.91-1.10],0.962061748864432
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,15627,234,0.92 [0.67-1.25],0.5737257731351149
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,18646,290,1.06 [0.83-1.36],0.6324349769419932
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,15910,241,0.94 [0.79-1.11],0.4471528286662419
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,15627,234,1.01 [0.92-1.10],0.8570833645036398
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,18258,289,1.07 [0.88-1.32],0.4899733535399263
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,18653,291,1.11 [0.74-1.67],0.6126150196685057
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",15803,235,1.01 [0.87-1.18],0.8677226733504135
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,18476,291,1.47 [0.93-2.31],0.0966377204302154
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,18650,288,1.39 [0.97-1.99],0.0723218453161818
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,18470,291,1.09 [0.80-1.48],0.5830232580213979
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,18230,284,1.01 [0.90-1.14],0.835260149433352
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAX,Protein max,18258,289,1.03 [0.93-1.13],0.6045659612493406
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,18887,296,1.24 [1.04-1.47],0.0163830093272286
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,15999,244,0.95 [0.85-1.06],0.3691041131745007
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,18745,294,0.88 [0.63-1.21],0.4165291525235332
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",16168,245,1.34 [1.05-1.70],0.0177645088089148
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,15703,236,0.92 [0.79-1.07],0.2658217580105778
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,18552,287,1.10 [0.87-1.39],0.4122750115697722
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,16136,244,0.68 [0.41-1.15],0.1501084564678337
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,18504,291,1.02 [0.88-1.19],0.7861554239190907
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",16126,243,0.99 [0.73-1.36],0.9733172282747712
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MDK,Midkine,18635,293,1.03 [0.85-1.26],0.7563213195947343
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,15777,238,1.10 [0.73-1.66],0.6361231126206971
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",15741,240,0.94 [0.82-1.08],0.4026116915797026
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,18230,284,0.98 [0.85-1.12],0.7244989518396574
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,15662,238,0.79 [0.58-1.07],0.1326017869178184
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,18620,288,0.95 [0.73-1.23],0.6880919293514676
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,15662,238,0.83 [0.54-1.26],0.3718872230676991
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,18827,296,1.10 [0.64-1.87],0.7375985836850719
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,16189,244,1.02 [0.68-1.54],0.908152711906533
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,15830,235,0.47 [0.28-0.78],0.0040894717814166
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,16136,244,1.09 [0.93-1.29],0.2788367046423098
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,18653,291,0.94 [0.86-1.03],0.1871516457907501
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,18620,288,0.87 [0.57-1.35],0.5392328207235899
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,18876,294,1.15 [0.76-1.75],0.5021775127219841
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,18654,292,0.99 [0.91-1.07],0.7470209321834551
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,18701,293,1.16 [0.68-1.97],0.5869361673740708
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,18258,289,0.96 [0.67-1.38],0.8230748946422068
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",18646,290,0.94 [0.83-1.07],0.3340102447515591
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,18806,293,0.91 [0.76-1.10],0.3403736327130277
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,18323,284,0.86 [0.67-1.09],0.206527529366044
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,15777,238,0.93 [0.75-1.14],0.4705611990794811
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,15830,235,1.09 [0.74-1.61],0.6571394985392495
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,18887,296,1.05 [0.82-1.36],0.6892667658263477
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,18654,292,1.17 [0.93-1.48],0.1760261532548615
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,18689,288,1.01 [0.89-1.13],0.9281185585800512
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,18646,290,0.98 [0.90-1.06],0.5726435377263378
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,18698,293,1.12 [0.85-1.47],0.4338014852325699
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,15777,238,0.99 [0.82-1.20],0.9265428577647348
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,18646,290,1.01 [0.94-1.08],0.7768968726898938
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,18617,290,0.89 [0.77-1.04],0.1573663429327898
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,18340,284,1.02 [0.83-1.26],0.826967709395118
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,16130,242,0.99 [0.88-1.11],0.8403449394277915
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,16161,245,1.00 [0.88-1.14],0.9823780332479204
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,18504,291,1.00 [0.90-1.11],0.9643361309952512
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,15703,236,1.15 [0.86-1.54],0.3308735249507996
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,15627,234,1.12 [0.94-1.33],0.2100489074104006
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,18646,290,1.08 [0.96-1.21],0.2240758622042938
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,18561,288,1.04 [0.91-1.19],0.5661856589167434
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,18035,284,1.01 [0.90-1.14],0.8075411785905886
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,18597,288,1.10 [0.92-1.31],0.2972627891863125
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,18698,292,1.26 [1.05-1.50],0.0125373612378964
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,18258,289,1.16 [0.84-1.61],0.3659012196455807
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,16189,244,1.06 [0.83-1.36],0.6173011032181499
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,18654,292,1.02 [0.83-1.26],0.8450896105885972
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,18299,284,1.25 [1.00-1.56],0.0462230357953537
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,18790,294,0.94 [0.81-1.08],0.3788007753137157
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,18634,292,0.94 [0.79-1.12],0.4876445571584699
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",15662,238,0.97 [0.75-1.25],0.820993250436751
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,15777,238,0.90 [0.72-1.13],0.374942982919997
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,15910,241,0.82 [0.60-1.11],0.1973737362963133
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,18623,290,0.89 [0.80-1.00],0.0438726875461559
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,15830,235,1.03 [0.84-1.24],0.8005921755245288
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,18830,294,0.95 [0.70-1.29],0.7557353097089765
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,16161,245,1.23 [0.82-1.86],0.3148734085969442
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,15910,241,1.34 [1.05-1.72],0.0194587673695864
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,15627,234,1.09 [0.80-1.50],0.5768941098114488
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,15627,234,1.07 [0.92-1.24],0.3763242830272583
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,18323,284,0.93 [0.81-1.07],0.3167961200905787
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,18561,288,1.00 [0.88-1.13],0.9741229029494728
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,18689,288,0.98 [0.86-1.12],0.7932727564972898
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,18654,292,0.87 [0.69-1.09],0.2229149621417144
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,16102,241,1.03 [0.78-1.36],0.8274476507489809
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,16208,243,1.30 [0.85-2.01],0.2301522214972755
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,15777,238,0.93 [0.77-1.12],0.4593569615555442
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",15662,238,0.86 [0.60-1.22],0.3940170424988959
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",16168,245,0.92 [0.64-1.32],0.652528902043565
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",18258,289,0.97 [0.67-1.42],0.8862410416828866
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",15589,234,1.17 [0.80-1.69],0.4155087726885955
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",16168,245,1.03 [0.87-1.22],0.7240698450760634
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",15703,236,1.21 [0.82-1.79],0.3445646108345519
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,18531,288,1.02 [0.86-1.21],0.8205064077403772
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,15777,238,1.31 [0.98-1.75],0.0704827614295518
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,18636,292,1.15 [0.99-1.34],0.058335750084123
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,18821,295,1.05 [0.84-1.31],0.6580207853870395
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,18698,293,0.98 [0.85-1.13],0.8091984677612614
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,15980,242,0.91 [0.78-1.06],0.2135864830233503
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,18323,284,0.97 [0.80-1.18],0.7643432372532059
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,15703,236,0.99 [0.86-1.13],0.8551899106948416
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",16161,245,1.21 [0.76-1.93],0.4166663055217924
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,15910,241,1.03 [0.92-1.15],0.6285865865824227
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",16136,244,0.94 [0.82-1.08],0.3832687604153894
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,18323,284,1.08 [0.79-1.47],0.6250081344763282
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,15662,238,1.07 [0.90-1.28],0.4577000237630222
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,16136,244,1.02 [0.92-1.14],0.6649703105795556
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,16130,242,1.03 [0.91-1.16],0.6543911671028428
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,15910,241,1.01 [0.81-1.27],0.8961908961078557
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,18258,289,1.16 [0.95-1.41],0.136773935573998
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,18561,288,1.03 [0.97-1.09],0.2943474893721332
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,16200,246,0.97 [0.85-1.10],0.596802563695702
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,15627,234,1.01 [0.75-1.35],0.9654340606125362
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,18340,284,1.02 [0.90-1.17],0.7151818238673013
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,15830,235,0.65 [0.43-0.98],0.0404371303233669
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",16189,244,1.14 [0.98-1.33],0.0924070539193763
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",15741,240,1.00 [0.86-1.16],0.9982278987805144
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,16168,245,0.93 [0.76-1.13],0.4737204538503071
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,16189,244,1.02 [0.90-1.15],0.7655166101157499
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,15662,238,0.88 [0.65-1.19],0.4165268792308098
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,15627,234,1.02 [0.76-1.35],0.9167569331767224
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,16200,246,0.94 [0.84-1.04],0.2274955003892581
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",15662,238,1.07 [0.77-1.47],0.6970482171755144
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,15741,240,1.13 [0.97-1.33],0.1263943565102031
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,15741,240,0.76 [0.59-0.99],0.0383151126851459
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,15777,238,0.92 [0.80-1.07],0.2924026427494891
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",15777,238,1.09 [0.88-1.36],0.4356589735000011
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,16168,245,0.86 [0.61-1.22],0.4064098992139086
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,18340,284,1.03 [0.87-1.20],0.7561979858679075
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,18654,292,0.83 [0.65-1.04],0.1091650648080966
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,15700,238,1.30 [1.07-1.59],0.0093313911356171
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,15662,238,1.12 [0.90-1.40],0.312199690871757
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,15830,235,1.13 [0.99-1.29],0.0597791435387418
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,18671,288,0.98 [0.80-1.20],0.8484178723352022
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,18230,284,1.03 [0.84-1.27],0.7751522853433472
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,15662,238,1.18 [0.92-1.51],0.1869134571782822
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,15777,238,1.02 [0.92-1.13],0.7183779887116108
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,18424,291,0.87 [0.73-1.03],0.1120509615505893
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,16130,242,1.19 [0.97-1.45],0.0973938657696351
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,18653,291,0.83 [0.67-1.01],0.0623145607338256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,15675,235,0.95 [0.75-1.21],0.6908681172318991
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,15712,239,0.98 [0.78-1.23],0.8827708578444874
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,15830,235,0.80 [0.45-1.42],0.4394139893705543
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,18230,284,0.90 [0.72-1.11],0.3135765470432841
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,16098,244,0.86 [0.65-1.15],0.314154751793985
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,16161,245,1.04 [0.72-1.49],0.8483298538672452
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",16168,245,0.96 [0.74-1.24],0.7460634937253071
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,18698,293,1.17 [0.80-1.71],0.4135688389858833
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,18340,284,0.89 [0.71-1.10],0.280318789877846
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,18745,294,1.17 [0.86-1.60],0.3179708821971492
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,18654,292,0.92 [0.63-1.35],0.6666188222206548
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,18821,295,1.09 [0.83-1.42],0.5409385935319895
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,18607,290,0.87 [0.76-0.99],0.0319926229532526
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,18710,288,1.02 [0.92-1.12],0.7091179320156423
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,18340,284,0.95 [0.76-1.19],0.6340288375935694
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,18621,290,1.00 [0.76-1.32],0.9748784673305402
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,16136,244,1.28 [0.91-1.80],0.160150978243211
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,18830,294,1.55 [1.08-2.21],0.0160883670866194
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,18258,289,1.04 [0.88-1.22],0.6506071723317277
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,16130,242,0.86 [0.68-1.08],0.1876447216522156
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,15674,236,1.32 [0.93-1.85],0.1158918301226321
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,16136,244,0.97 [0.84-1.11],0.6477082311154203
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",18230,284,0.99 [0.87-1.14],0.8992508189109314
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,15662,238,1.05 [0.76-1.45],0.7667391328002127
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,15662,238,1.01 [0.84-1.22],0.8851630911559535
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,15703,236,1.03 [0.71-1.50],0.8577220266215114
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,18633,291,1.21 [0.87-1.69],0.2630984247078396
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,18698,293,1.20 [0.88-1.63],0.2604400371804506
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,15703,236,0.95 [0.73-1.23],0.7015741927935506
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,15703,236,0.99 [0.68-1.42],0.9355477500741802
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,18204,287,1.13 [0.91-1.41],0.2733241152167062
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,15910,241,1.06 [0.90-1.24],0.4871616777554193
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,18698,293,1.06 [0.83-1.36],0.6295365102301704
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,18710,288,1.28 [0.91-1.81],0.1607154008145024
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,16130,242,0.96 [0.86-1.08],0.5296063550582442
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,16168,245,0.95 [0.55-1.63],0.8491439663703417
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,16208,243,1.00 [0.84-1.20],0.9948793470186812
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,18876,294,1.53 [1.08-2.18],0.0172192392233234
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,15703,236,1.00 [0.86-1.16],0.9641233568882102
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",18646,290,1.04 [0.93-1.15],0.5037587448369084
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",18340,284,1.04 [0.87-1.23],0.6914279487722275
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,15741,240,1.01 [0.85-1.19],0.9507634051792974
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,16168,245,0.83 [0.59-1.16],0.2830158612359841
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,15662,238,1.06 [0.89-1.26],0.4933117724843375
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,15910,241,0.93 [0.72-1.19],0.5492526435129634
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,18230,284,1.01 [0.81-1.26],0.9347435980640928
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",16136,244,0.96 [0.85-1.08],0.5120604478598985
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,15662,238,1.01 [0.84-1.22],0.8778907075201966
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,15662,238,0.83 [0.58-1.18],0.2894563670044395
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,18504,291,1.66 [0.78-3.57],0.191249285138041
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,16189,244,1.14 [0.77-1.69],0.5089442698999264
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,16161,245,1.49 [0.93-2.38],0.0995457477288597
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,15463,233,1.30 [0.86-1.96],0.2098760820771935
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,18690,293,1.09 [0.82-1.45],0.5487988189150784
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,18654,292,0.99 [0.87-1.14],0.9369217869333376
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,18230,284,0.92 [0.75-1.15],0.4775150650063259
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,15741,240,0.91 [0.69-1.19],0.483227500180271
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,16129,244,0.95 [0.80-1.13],0.5962434014811926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,15777,238,0.96 [0.78-1.16],0.6532917402417656
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,15700,238,1.14 [0.90-1.45],0.2759878714015384
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,15703,236,1.25 [0.70-2.22],0.4472602061032084
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,18650,288,1.17 [0.76-1.79],0.4865928334131539
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,16064,242,1.04 [0.87-1.23],0.6830960841369226
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,18504,291,0.89 [0.77-1.03],0.1261749062043387
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,15627,234,0.84 [0.59-1.21],0.3617924771516533
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,16168,245,0.96 [0.79-1.16],0.6686134422656416
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,18654,292,0.92 [0.58-1.45],0.7128557045534841
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,15662,238,1.05 [0.94-1.17],0.39787231574746
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",18258,289,1.07 [0.89-1.28],0.4594012169472318
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",15662,238,1.05 [0.77-1.43],0.7698180518542138
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",18258,289,1.09 [0.89-1.33],0.3952073304787596
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,18887,296,1.41 [0.74-2.70],0.2946891331280755
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,16200,246,1.06 [0.60-1.89],0.8381816171724304
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,18887,296,0.81 [0.59-1.11],0.1823454713847436
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,15936,243,1.18 [0.80-1.72],0.4061762055712882
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,18653,291,1.09 [0.80-1.50],0.5857519364268952
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,15703,236,0.81 [0.55-1.19],0.2827402897566617
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,15703,236,1.14 [1.03-1.27],0.0132633466356772
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,16189,244,0.79 [0.60-1.03],0.0812125987914815
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,18323,284,0.97 [0.90-1.04],0.3464421107025663
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,18646,290,0.95 [0.78-1.16],0.630252629231041
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,15662,238,0.97 [0.71-1.33],0.8467193292873505
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,18230,284,1.02 [0.89-1.17],0.7440454801063474
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,18654,292,1.26 [0.99-1.60],0.0598619985301402
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,16200,246,0.85 [0.59-1.23],0.3917470993702716
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,18653,291,1.05 [0.78-1.42],0.7408646257054985
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,18830,294,1.03 [0.87-1.21],0.7489781792103829
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,18653,291,1.64 [1.15-2.32],0.0057196424188902
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,16208,243,1.02 [0.89-1.17],0.7607448935548988
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,16168,245,0.94 [0.65-1.34],0.7187926109211319
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,18778,294,1.56 [1.07-2.27],0.0216167990134881
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,18654,292,1.13 [0.78-1.62],0.5198564275256836
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,18340,284,1.00 [0.81-1.23],0.9733318658175528
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,15777,238,0.88 [0.61-1.28],0.5084880855120344
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,18821,295,0.90 [0.76-1.05],0.1814899845760347
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",16189,244,1.07 [0.91-1.27],0.4191940523333829
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,16161,245,1.34 [0.95-1.90],0.0993982932244454
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,18608,289,0.94 [0.83-1.06],0.3168931769540099
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,18698,293,0.93 [0.76-1.13],0.4566575826310524
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,18646,290,0.78 [0.57-1.05],0.1021599676577357
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,18230,284,1.07 [0.81-1.42],0.6415985647946406
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,18653,291,1.20 [0.79-1.80],0.3922235164700141
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,18821,295,0.88 [0.54-1.42],0.5999312436156389
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,18653,291,0.94 [0.86-1.03],0.1997219740140471
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,18646,290,1.01 [0.89-1.15],0.8500119793639712
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,16130,242,1.05 [0.93-1.18],0.4543270289787845
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,18802,294,1.06 [0.80-1.40],0.6952017281683287
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,18876,294,1.00 [0.85-1.18],0.9946579937065492
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,15741,240,1.03 [0.63-1.69],0.8916054467744643
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,15662,238,0.88 [0.68-1.15],0.3614422677898171
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,16110,243,1.01 [0.87-1.16],0.9283242756015704
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],18561,288,0.94 [0.78-1.13],0.5057204251619322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,18654,292,1.05 [0.85-1.29],0.666452135993983
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,15703,236,1.01 [0.87-1.18],0.8735420265688326
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,15662,238,0.69 [0.44-1.09],0.1095669148494694
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,15662,238,1.15 [0.79-1.69],0.4636391550058298
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,18258,289,1.01 [0.77-1.31],0.9614863126249904
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,15703,236,0.99 [0.65-1.50],0.962377237070982
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,18446,291,0.80 [0.67-0.96],0.0165029039116482
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,16168,245,1.22 [0.93-1.60],0.1598894099844399
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,18226,287,1.10 [0.92-1.31],0.3095276623847485
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,15910,241,0.85 [0.68-1.07],0.1700313834573419
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,16136,244,1.02 [0.85-1.21],0.8672169382043562
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,18561,288,0.93 [0.67-1.31],0.6913951650027406
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,18654,292,1.20 [0.95-1.52],0.1302445664571953
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,15910,241,1.00 [0.83-1.22],0.9828707864472744
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,15237,229,0.96 [0.86-1.06],0.431300555654823
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,18469,289,0.93 [0.78-1.12],0.4420553911843625
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,18710,288,1.09 [0.84-1.41],0.5370139937239901
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,18561,288,0.97 [0.83-1.12],0.6601871036167293
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,15700,238,0.90 [0.69-1.18],0.4645412266704114
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,16161,245,1.01 [0.90-1.13],0.8798999077450915
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,15741,240,0.93 [0.77-1.11],0.4103704624520399
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,18561,288,0.93 [0.74-1.18],0.561106161568301
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,16151,243,1.16 [0.63-2.14],0.6388726327421808
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,16161,245,1.16 [0.86-1.55],0.3283017267850729
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,18650,288,1.39 [1.03-1.88],0.0337740692230644
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,18553,290,0.95 [0.82-1.10],0.4987046917067664
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,18778,294,1.18 [0.69-2.03],0.5389809076019334
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,15777,238,1.08 [0.81-1.45],0.6041440162380032
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,15700,238,1.01 [0.79-1.28],0.9468068208132
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,16136,244,0.99 [0.80-1.22],0.8992009774303016
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,16168,245,1.04 [0.86-1.27],0.6627668300812477
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",15741,240,1.01 [0.85-1.21],0.8926194364845537
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,18821,295,1.01 [0.94-1.08],0.8671073177987434
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,18555,292,1.05 [0.80-1.37],0.7162149092903148
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,15662,238,1.03 [0.84-1.26],0.804889689911849
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,18340,284,0.84 [0.67-1.04],0.1103522913750456
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,18226,287,0.87 [0.75-1.02],0.0808439915934781
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,18504,291,0.97 [0.88-1.07],0.5582334929273005
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,16168,245,1.00 [0.90-1.11],0.945656565764816
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",15910,241,1.11 [0.87-1.41],0.3977692861128846
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,18323,284,0.98 [0.81-1.19],0.8252789643523517
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,15741,240,0.79 [0.57-1.08],0.1430341933168358
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,15600,234,0.93 [0.73-1.20],0.582073690744403
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,18258,289,1.00 [0.84-1.18],0.9864246224240962
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,15703,236,1.05 [0.76-1.45],0.7826921816180412
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,16039,244,0.87 [0.59-1.28],0.4724322053133124
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,16161,245,1.07 [0.77-1.49],0.6997933686505529
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,15662,238,0.95 [0.80-1.14],0.5932692206233937
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,18804,294,1.23 [0.85-1.79],0.2723766913343372
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,18654,292,0.98 [0.66-1.45],0.931511310299447
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,18340,284,0.87 [0.70-1.09],0.2395826463857965
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,15910,241,1.01 [0.86-1.19],0.8702150009482519
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,18654,292,0.92 [0.75-1.13],0.4076415585944807
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,18646,290,1.00 [0.83-1.21],0.992662394658244
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,15830,235,0.93 [0.70-1.24],0.6107498071564239
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,15627,234,0.78 [0.53-1.17],0.2306789371795067
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,18258,289,0.99 [0.80-1.22],0.9202680261452082
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,16136,244,1.13 [0.75-1.69],0.5605498158318826
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,15700,238,1.04 [0.91-1.20],0.5622418820396835
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,15795,235,0.90 [0.68-1.19],0.4679285458164505
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,16168,245,1.00 [0.84-1.18],0.9590959070709432
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,18810,293,1.26 [0.78-2.02],0.3405684395383525
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,16168,245,1.01 [0.62-1.64],0.9654711984400516
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,18653,291,0.97 [0.73-1.29],0.8404638405481493
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,16136,244,0.80 [0.54-1.17],0.2517774517290564
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,16136,244,0.88 [0.62-1.25],0.4716773466470325
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,16130,242,0.88 [0.65-1.20],0.4177763223844583
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,15627,234,1.01 [0.83-1.22],0.9276659767691454
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,16130,242,0.98 [0.75-1.27],0.8643689192680442
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,18887,296,1.04 [0.81-1.35],0.7424209568674086
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,16136,244,1.01 [0.86-1.19],0.9204917813117718
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,16189,244,1.00 [0.88-1.13],0.9384724334507176
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,18797,293,1.24 [0.97-1.59],0.0825401364007493
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,18561,288,1.15 [0.83-1.59],0.4163269616163334
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,18821,295,0.93 [0.78-1.12],0.4398555955790307
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,18653,291,1.00 [0.87-1.16],0.985166568420218
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,15627,234,0.85 [0.64-1.12],0.2393602409056041
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",15627,234,1.10 [0.88-1.38],0.3874690987490029
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",15662,238,1.10 [0.91-1.33],0.3352754479117258
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",15830,235,0.99 [0.88-1.12],0.8551821306381238
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,18887,296,0.95 [0.82-1.09],0.467253737846004
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,18710,288,0.97 [0.86-1.10],0.6451410542356592
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,18230,284,1.21 [0.82-1.78],0.3389110113706463
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,18653,291,1.05 [0.72-1.52],0.813530291963477
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,18887,296,0.96 [0.71-1.29],0.7755410068043201
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,15627,234,0.70 [0.50-0.99],0.0467537363710337
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,15830,235,1.11 [0.67-1.84],0.6953457883664166
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,16200,246,1.00 [0.82-1.22],0.9852796054672076
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,15627,234,1.14 [0.95-1.38],0.1666329232525966
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,16168,245,1.00 [0.91-1.11],0.9340787724757706
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,18710,288,1.03 [0.94-1.12],0.5406979509395708
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",18230,284,0.94 [0.75-1.18],0.6024187285368626
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,15777,238,0.91 [0.70-1.17],0.452186722490464
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,15627,234,1.07 [0.86-1.34],0.5258187775447443
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,15662,238,1.02 [0.82-1.27],0.8581558464340535
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,15703,236,1.12 [0.85-1.48],0.424903510087731
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,18887,296,1.28 [0.82-2.01],0.2786350768260844
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,18654,292,0.89 [0.74-1.07],0.2188504532331142
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,18654,292,0.96 [0.68-1.36],0.8371955761398948
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,15741,240,0.74 [0.45-1.21],0.2277994992433758
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,15830,235,0.86 [0.57-1.30],0.4682311879389831
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,16208,243,0.74 [0.46-1.19],0.2128173423348983
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,15703,236,1.02 [0.92-1.12],0.7592703375339649
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,16089,243,1.01 [0.89-1.14],0.908708289937508
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,18258,289,1.05 [0.87-1.27],0.5982249117580798
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,15627,234,1.19 [0.96-1.48],0.1135019173674687
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,15777,238,1.01 [0.83-1.22],0.9305772925174148
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",18535,288,1.02 [0.89-1.16],0.8177779316684755
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,16208,243,1.11 [0.95-1.30],0.184506484875071
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",16189,244,0.94 [0.74-1.19],0.5829437210599814
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,18876,294,1.11 [0.74-1.66],0.6186889287733969
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,18797,296,0.89 [0.70-1.14],0.3617684688050833
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,16017,244,1.33 [0.87-2.04],0.1924245114917321
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,15662,238,0.97 [0.78-1.22],0.8185752410859688
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,15777,238,1.05 [0.87-1.28],0.6047392574771813
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,15703,236,0.98 [0.86-1.12],0.7863754532750198
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,16168,245,0.99 [0.89-1.10],0.812679158823773
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,16136,244,1.34 [1.06-1.69],0.0137942602797451
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,15627,234,0.97 [0.84-1.11],0.6247922021170842
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,18504,291,1.20 [0.84-1.71],0.3165871186436657
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,15830,235,0.85 [0.63-1.16],0.3079827023393934
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,16208,243,1.01 [0.61-1.67],0.9761085896453868
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PI3,Elafin,18418,294,1.08 [0.90-1.30],0.3803523358943923
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",16168,245,1.06 [0.91-1.24],0.4758821572635637
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,18424,288,1.29 [0.98-1.71],0.0700496825095342
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,18646,290,0.93 [0.79-1.11],0.4283034809492678
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,18654,292,1.16 [0.81-1.66],0.4118116717008458
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,15703,236,1.04 [0.83-1.30],0.7239297222589002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,18654,292,0.92 [0.72-1.17],0.4886585194697702
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,18653,291,0.90 [0.75-1.08],0.2572212175409766
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,15830,235,0.94 [0.79-1.12],0.4880303010210078
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,15600,234,1.11 [0.96-1.29],0.1488511247011558
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,16189,244,0.92 [0.58-1.46],0.7125658701278439
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,15662,238,1.07 [0.86-1.32],0.5486682986038521
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,18653,286,0.83 [0.70-0.98],0.0284861702104674
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,15910,241,1.10 [0.94-1.30],0.2346529438998003
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,18504,291,1.06 [0.89-1.27],0.5056942226249137
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,18698,293,1.13 [0.77-1.64],0.5360274229725415
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,18862,296,1.17 [0.93-1.47],0.17689611988072
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",18638,291,1.06 [0.87-1.29],0.5473194086877329
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,18710,288,1.03 [0.92-1.16],0.6081378032857734
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,18654,292,0.76 [0.56-1.03],0.0734717920416046
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,18827,296,1.11 [0.91-1.36],0.3177465616467736
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,18654,292,0.85 [0.58-1.23],0.38745614638659
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,18507,288,1.10 [0.76-1.59],0.6189951848339559
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",16161,245,0.76 [0.62-0.93],0.0084117158908108
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",15703,236,1.14 [0.85-1.51],0.3805470855262783
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",16161,245,0.98 [0.86-1.11],0.7192764095027235
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,16161,245,1.10 [0.92-1.31],0.2916605506441078
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,15818,242,1.13 [0.63-2.02],0.6902727083143093
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,18258,289,1.28 [0.98-1.68],0.0712177772532299
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,18653,291,1.11 [0.87-1.41],0.4015329479579447
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,18653,291,0.97 [0.83-1.13],0.6698899086356664
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,16131,243,1.06 [0.85-1.32],0.5940215404703341
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,18829,296,0.79 [0.60-1.04],0.087665372151945
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,18230,284,0.87 [0.61-1.23],0.4166132302481565
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,16161,245,1.39 [0.94-2.03],0.0955598624414628
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,18646,290,0.98 [0.86-1.11],0.7356931873548327
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,18804,296,1.53 [1.01-2.31],0.0447725918782274
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,18592,291,1.05 [0.84-1.30],0.6655941054477948
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,18576,290,1.00 [0.95-1.06],0.9736722531064468
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,15662,238,0.86 [0.71-1.04],0.1235034604772828
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,15662,238,1.06 [0.86-1.31],0.5670344637634481
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,15777,238,1.30 [1.07-1.58],0.008249203935093
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,18230,289,0.94 [0.85-1.02],0.1473117999981636
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,16208,243,1.03 [0.85-1.24],0.7656663971082737
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,16161,245,1.11 [0.96-1.29],0.164043268907134
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,18620,288,1.00 [0.97-1.04],0.9414963237008844
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,15741,240,0.94 [0.76-1.18],0.6161831478150918
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,15700,238,1.11 [0.85-1.44],0.457948249479421
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",18340,284,0.92 [0.83-1.01],0.0924400482446436
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,18561,288,0.93 [0.47-1.83],0.8241716771649652
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,18698,293,0.91 [0.63-1.32],0.6256170708475708
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,15703,236,1.31 [1.03-1.66],0.0301295438221014
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,15703,236,0.89 [0.57-1.39],0.6205134214657562
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",18561,288,1.01 [0.74-1.36],0.9737984711437604
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,15741,240,1.00 [0.84-1.19],0.9995607648294226
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,16208,243,0.81 [0.52-1.24],0.3251589510984729
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,18323,284,1.49 [1.10-2.00],0.0087568577038524
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,18710,288,1.00 [0.70-1.42],0.9802221896412776
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,16200,246,0.72 [0.52-1.00],0.050903260322631
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,16088,243,1.03 [0.89-1.19],0.6746427197172934
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,18821,295,1.02 [0.82-1.28],0.8381728652794338
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,18669,295,0.97 [0.88-1.08],0.6348405515750162
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,15910,241,0.93 [0.75-1.15],0.4935143068051224
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",16200,246,0.94 [0.77-1.15],0.5431000181184352
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,15703,236,1.03 [0.70-1.51],0.8871932829343441
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,18230,284,0.96 [0.68-1.35],0.8093934322967
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,15703,236,0.95 [0.76-1.18],0.6342510843463558
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,16189,244,1.01 [0.80-1.27],0.94376002151241
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,18561,288,0.90 [0.76-1.08],0.2637211134053921
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,16130,242,1.01 [0.87-1.17],0.9222099830395668
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,18698,293,1.00 [0.89-1.11],0.934801856528972
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,15910,241,0.91 [0.75-1.10],0.3425786788135736
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,16168,245,0.94 [0.80-1.10],0.4441759686358464
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,16168,245,1.10 [0.82-1.47],0.5321932925295765
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,18653,291,1.00 [0.88-1.14],0.9888052905833848
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,18876,294,1.04 [0.93-1.16],0.5027817220724322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,16136,244,1.03 [0.93-1.14],0.5635128820072781
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,18504,291,1.07 [0.82-1.38],0.6286458719785505
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,15777,238,1.00 [0.85-1.18],0.998090049950594
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,18587,291,1.01 [0.92-1.12],0.8065542860734425
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,18230,284,0.88 [0.72-1.08],0.2337267053598471
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,15627,234,0.91 [0.55-1.51],0.7190873568859983
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,16200,246,1.21 [0.87-1.67],0.2595355872874016
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,16130,242,0.71 [0.49-1.03],0.0746002684894868
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,18769,295,1.33 [0.97-1.82],0.0745800607415855
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,18128,288,1.04 [0.93-1.17],0.480989548698484
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,15947,242,0.81 [0.66-0.99],0.0435856389724506
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",18340,284,0.95 [0.82-1.11],0.5276989037438826
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",18876,294,0.89 [0.77-1.04],0.1363693450352785
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,18830,294,0.88 [0.74-1.04],0.135905295559266
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,18340,284,0.97 [0.66-1.41],0.8619481236340554
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,18620,288,0.87 [0.56-1.36],0.5412374431827328
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,16200,246,0.98 [0.77-1.25],0.8791413487175036
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,16200,246,0.92 [0.72-1.19],0.5462733382983327
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,18340,284,1.03 [0.85-1.25],0.7840744170174252
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,15777,238,0.85 [0.56-1.29],0.4491516821585551
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,18653,291,0.99 [0.87-1.12],0.8135262310526217
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,16125,243,0.98 [0.84-1.15],0.8467030268454555
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,18340,284,1.16 [0.93-1.45],0.18959436072859
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,15662,238,1.07 [0.80-1.42],0.6645020339887625
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,15830,235,0.98 [0.89-1.09],0.7302692492780414
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,18230,284,1.05 [0.90-1.23],0.5097001803178565
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,18821,295,1.09 [0.95-1.25],0.2158477083793752
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,16161,245,1.24 [0.97-1.59],0.0794600006354388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,18722,293,1.14 [0.76-1.71],0.540297429999943
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,15662,238,0.88 [0.58-1.33],0.531924199180357
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,18646,290,1.03 [0.84-1.26],0.7965575170771062
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,16213,244,1.13 [0.70-1.82],0.6128783129954634
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,15720,235,1.08 [0.91-1.29],0.3718820901002346
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,15703,236,1.32 [1.04-1.67],0.0225027895279592
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,15741,240,0.98 [0.70-1.37],0.9079942176106912
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,18745,294,1.13 [0.95-1.35],0.1764755450920866
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,15703,236,1.29 [0.93-1.79],0.1325085828186619
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,18593,291,0.92 [0.71-1.19],0.524849397085984
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,16161,245,0.77 [0.56-1.07],0.1225723983444703
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,18566,286,1.09 [0.85-1.41],0.4842119927825259
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,18258,289,1.00 [0.91-1.09],0.952896105943385
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,18830,294,1.15 [0.75-1.74],0.5259473866108997
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,18198,290,0.86 [0.69-1.08],0.1901489040835982
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,15910,241,0.91 [0.59-1.41],0.6699355631971142
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,16060,244,1.16 [0.75-1.82],0.503695555305858
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,16136,244,0.84 [0.66-1.08],0.179988099923325
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,16136,244,1.04 [0.99-1.09],0.1208746630525968
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,18504,291,0.96 [0.88-1.05],0.3993581791755237
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,18646,290,0.99 [0.84-1.17],0.9284956303863257
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,18230,284,0.95 [0.75-1.21],0.6993222244659469
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,15627,234,0.92 [0.61-1.39],0.6789315961541531
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,16168,245,0.77 [0.59-1.00],0.0482749431131309
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,15777,238,1.09 [0.88-1.36],0.4431546450396837
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,18561,288,0.87 [0.72-1.06],0.1633584347307216
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,18474,291,0.85 [0.64-1.13],0.2587809020957571
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,18429,291,0.84 [0.63-1.12],0.2389916336856754
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,18646,290,0.82 [0.66-1.00],0.0546907298185444
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,15703,236,0.83 [0.65-1.04],0.1070681500207499
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,18646,290,1.00 [0.89-1.12],0.9543373838629782
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,18230,284,0.88 [0.73-1.06],0.1749930193039062
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,15271,230,0.98 [0.87-1.10],0.7538856358483446
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",18258,289,1.18 [0.84-1.66],0.3357578332334989
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,18544,289,1.05 [0.75-1.46],0.7818189897347703
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,15588,234,1.14 [0.91-1.44],0.2570502429833947
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,16189,244,0.92 [0.79-1.07],0.2630517280997555
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,15777,238,0.91 [0.78-1.07],0.2617607394876428
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,18646,290,0.88 [0.66-1.19],0.4152383605779014
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,18258,289,0.90 [0.69-1.19],0.4690338864986285
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,18323,284,1.15 [0.93-1.42],0.2043850535765744
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,15703,236,0.98 [0.76-1.25],0.8444995188692141
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,18504,291,1.02 [0.89-1.17],0.7650061064371814
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,18689,288,0.96 [0.86-1.07],0.4674133803313955
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,15676,235,1.20 [0.90-1.59],0.2151323069876637
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,16189,244,0.84 [0.56-1.27],0.4176026508757273
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,16200,246,0.74 [0.43-1.29],0.2888836796134315
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,18887,296,0.82 [0.57-1.17],0.2692318578508458
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,16136,244,1.14 [0.89-1.47],0.289692984485284
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,16136,244,1.12 [0.63-1.97],0.7022240724501191
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,18612,288,1.01 [0.65-1.55],0.9747424474556426
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,18442,290,1.02 [0.74-1.39],0.923882579385114
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,16161,245,0.90 [0.65-1.25],0.5310159042359135
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,18887,296,0.81 [0.54-1.22],0.314144948091295
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,16189,244,1.23 [0.84-1.82],0.2931058186190138
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,15830,235,0.94 [0.76-1.17],0.6059374650623908
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,18165,289,0.97 [0.79-1.18],0.7495840225361099
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,15910,241,1.03 [0.77-1.37],0.8654850702051736
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,18646,290,0.97 [0.79-1.19],0.7749525067820424
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,18753,292,1.00 [0.91-1.09],0.9513374978636492
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,18821,295,0.96 [0.72-1.27],0.7551514207990268
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,16130,242,0.93 [0.74-1.17],0.5440235558658392
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,18258,289,0.86 [0.70-1.06],0.1618562224169033
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,15741,240,0.64 [0.45-0.91],0.0118252416317136
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,15662,238,1.14 [1.01-1.28],0.0292177035539192
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,16213,244,0.95 [0.66-1.35],0.7590324436413515
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,18561,291,0.92 [0.71-1.18],0.4897963917274363
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,18671,295,1.14 [0.77-1.68],0.5225116731004145
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,15888,238,1.25 [0.99-1.59],0.0644432774594656
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,16189,244,0.97 [0.77-1.22],0.7876254813352296
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,16189,244,1.03 [0.92-1.15],0.660023662361388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,16189,244,0.97 [0.84-1.12],0.6523143360092074
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,16130,242,0.99 [0.81-1.21],0.916779972787332
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,15662,238,1.09 [0.90-1.31],0.3815550696352303
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,18340,284,0.94 [0.82-1.08],0.3640947051903581
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,15662,238,0.98 [0.85-1.13],0.7712337235982603
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,15700,238,0.98 [0.79-1.22],0.8710040578233333
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,16130,242,1.02 [0.78-1.33],0.8815519975429068
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,18646,290,0.87 [0.69-1.10],0.2511774975319643
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,18258,289,1.06 [0.86-1.31],0.5912653450798265
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,15830,235,0.97 [0.82-1.15],0.751405518121411
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,18230,284,0.82 [0.67-1.00],0.0518409059823619
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,18340,284,0.93 [0.78-1.12],0.4501702662010912
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,15777,238,0.90 [0.73-1.11],0.3125528247358431
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,18230,284,1.04 [0.83-1.30],0.7424094005724764
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,15910,241,1.08 [0.87-1.33],0.4824928869820726
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,15703,236,1.38 [0.92-2.08],0.121668868586802
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,16130,242,1.17 [0.93-1.46],0.1707342307226415
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,15741,240,0.85 [0.66-1.08],0.1741745461342718
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,15700,238,0.97 [0.66-1.42],0.8746359583455441
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,18230,284,1.09 [0.88-1.35],0.4363018783561339
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,15703,236,1.00 [0.83-1.20],0.9720527673099418
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,15910,241,0.97 [0.77-1.24],0.8360602600765603
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,18230,284,1.25 [0.96-1.62],0.0920473676825923
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,18778,294,1.17 [0.96-1.44],0.1233780547371375
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,18258,289,0.99 [0.72-1.36],0.9618098958869256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,15627,234,0.89 [0.66-1.20],0.4365298249321186
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,18230,284,0.88 [0.72-1.07],0.2056380825637689
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,16168,245,1.16 [0.86-1.57],0.334719166569225
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,18234,291,0.85 [0.69-1.04],0.1120300064073121
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,16168,245,0.96 [0.82-1.13],0.652217159689976
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,15662,238,0.99 [0.75-1.30],0.9205020174777968
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,15627,234,0.90 [0.68-1.20],0.4799989593249043
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,15777,238,1.00 [0.83-1.19],0.9615721534694248
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,18561,288,1.07 [0.93-1.22],0.3501101386984951
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,18561,288,1.03 [0.85-1.24],0.7915330485034289
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,16136,244,1.01 [0.83-1.23],0.9105451435346308
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,15703,236,1.01 [0.83-1.22],0.9328499191196622
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,15741,240,1.02 [0.90-1.15],0.7933176822580797
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,16130,242,1.13 [0.90-1.42],0.2803839971645173
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,18323,284,0.76 [0.55-1.03],0.0796836693398931
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,15741,240,0.78 [0.43-1.39],0.3910448279767265
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,16168,245,1.17 [0.97-1.41],0.0968510597892325
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,18565,289,1.23 [1.01-1.50],0.0365864252595894
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,18887,296,1.18 [1.00-1.40],0.056453104368378
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,18887,296,1.08 [0.93-1.27],0.323842515194538
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,16130,242,1.26 [0.94-1.68],0.1176973598867832
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,18650,288,1.25 [1.03-1.52],0.0224922720637957
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,15703,236,0.87 [0.65-1.17],0.3666911465684128
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,18654,292,0.93 [0.65-1.33],0.6951678660994436
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REN,Renin,18653,291,1.07 [0.96-1.21],0.227653867113794
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,15703,236,1.12 [0.83-1.52],0.459910403112115
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,15627,234,0.86 [0.59-1.25],0.433621718016547
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,18561,288,1.04 [0.79-1.38],0.7713350111626789
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RETN,Resistin,18623,294,0.92 [0.72-1.18],0.5217154513060842
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",15662,238,1.03 [0.81-1.33],0.7943022280272258
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,16130,242,1.45 [0.84-2.51],0.1782847635424169
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,16168,245,1.01 [0.86-1.19],0.8845437486218274
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,15910,241,0.99 [0.81-1.20],0.920274359824106
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,18821,295,0.95 [0.69-1.31],0.7658024802251788
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,18821,295,0.94 [0.65-1.36],0.7449008906330894
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,16168,245,1.04 [0.84-1.27],0.7295920725058086
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,18340,284,1.03 [0.88-1.20],0.7359237493336522
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,18409,291,1.00 [0.91-1.09],0.9559810679778384
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,15703,236,1.06 [0.82-1.37],0.679395188180197
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,15830,235,0.88 [0.68-1.14],0.3374991129997169
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,18780,293,0.89 [0.75-1.06],0.1927217745356659
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,16189,244,1.01 [0.89-1.15],0.8555051125786268
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,15662,238,1.03 [0.86-1.23],0.729339019893217
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,16168,245,1.07 [0.84-1.35],0.5869679697246735
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,15806,235,1.20 [0.96-1.49],0.1058263197574114
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,16208,243,1.01 [0.62-1.64],0.9629985112759392
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,15741,240,1.12 [0.86-1.44],0.4015260921784217
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,18563,290,0.92 [0.83-1.01],0.078827029078031
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,15697,236,1.14 [0.72-1.81],0.5667414509621916
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,16098,240,0.84 [0.55-1.29],0.4191369674924229
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,16168,245,1.01 [0.79-1.30],0.9063268772948884
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,18802,296,1.12 [0.76-1.65],0.561041483028019
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,15741,240,1.08 [0.72-1.61],0.7020095141778798
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,15703,236,1.01 [0.74-1.38],0.96123778695058
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,15703,236,1.02 [0.71-1.45],0.9276999207737672
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,15910,241,0.95 [0.78-1.15],0.6175263363759151
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,18230,284,0.98 [0.83-1.15],0.8226742287845786
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,15910,241,1.02 [0.83-1.26],0.848913437954532
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,15741,240,0.91 [0.77-1.07],0.2538338102626447
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,18650,288,0.89 [0.57-1.39],0.621785921697302
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,18821,295,1.11 [0.70-1.74],0.6587250798285234
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,15741,240,1.00 [0.50-2.00],0.9912920610910378
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,18653,291,1.14 [0.82-1.57],0.4420159661269844
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,18561,288,0.95 [0.74-1.22],0.6758746003611044
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,15703,236,1.10 [0.74-1.64],0.6423868860024049
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,15910,241,0.90 [0.75-1.08],0.2549659986866265
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,15777,238,0.85 [0.61-1.18],0.3295521464973198
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,15741,240,0.74 [0.53-1.06],0.097259448335495
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,15662,238,0.90 [0.65-1.24],0.522462731502891
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,15777,238,1.03 [0.94-1.14],0.501413766897375
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,18230,284,1.07 [0.86-1.33],0.5262128260532243
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,18230,284,1.02 [0.87-1.19],0.8124903455419308
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,15700,238,1.07 [0.93-1.23],0.3241174819650435
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,18504,291,0.79 [0.58-1.08],0.1374810494641929
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,18830,294,1.07 [0.74-1.55],0.7237490166268554
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,18561,288,0.87 [0.61-1.25],0.4558520322385385
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,15662,238,0.88 [0.67-1.16],0.3683990657001534
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",16168,245,0.94 [0.82-1.07],0.3246840109279743
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,18830,294,1.63 [1.23-2.14],0.0005710596716277
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,18230,284,0.99 [0.90-1.10],0.9183172180608076
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,18821,295,0.97 [0.82-1.15],0.7422628608186183
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,15662,238,1.07 [0.77-1.47],0.6918656404311035
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,18516,289,0.93 [0.74-1.17],0.5266450357820301
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,18383,288,0.93 [0.80-1.07],0.2986720819243538
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,15703,236,1.24 [0.88-1.75],0.2141204808880739
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,16168,245,1.22 [0.98-1.52],0.075606297663487
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,18226,287,1.13 [0.96-1.32],0.146765893357478
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,16130,242,1.06 [0.82-1.36],0.673584106634168
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,18698,293,0.95 [0.79-1.14],0.5785789767041166
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,16168,245,1.00 [0.78-1.27],0.9682936909385176
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,18323,284,0.84 [0.68-1.03],0.0947448975429549
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,16213,244,1.35 [1.02-1.80],0.0387522286850234
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,16168,245,1.06 [0.68-1.64],0.8052374529993483
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,15700,238,0.92 [0.72-1.19],0.5375640475513309
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,18646,290,1.03 [0.89-1.19],0.6827584388376976
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,15910,241,0.96 [0.81-1.14],0.6490100093505637
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,16140,244,1.02 [0.91-1.14],0.7082566450413867
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,15662,238,1.10 [0.81-1.51],0.5319170790826707
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,15662,238,0.74 [0.55-1.01],0.055659503909825
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,15910,241,1.11 [0.94-1.32],0.2164606702405188
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,16168,245,0.86 [0.56-1.33],0.5059717284428904
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,16169,245,1.07 [0.76-1.51],0.6887719385964628
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,18561,288,0.99 [0.87-1.12],0.8446310387794815
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,18821,295,1.00 [0.71-1.40],0.977675967507912
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,18258,289,0.90 [0.73-1.11],0.3059399164753315
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,18150,287,1.03 [0.74-1.44],0.8575726869604765
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,18887,296,0.99 [0.77-1.27],0.9392471718665566
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,18821,295,1.13 [0.78-1.62],0.5141168099167175
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,18752,293,1.18 [0.87-1.61],0.2954550463889479
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,18650,288,1.10 [0.80-1.49],0.5658318116226561
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,18657,288,0.94 [0.78-1.13],0.509671418656515
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,15662,238,1.03 [0.68-1.56],0.8775598382751134
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,15830,235,1.36 [0.85-2.18],0.2058864362318033
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,18689,288,1.09 [0.97-1.23],0.1586962615219701
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,18340,284,1.53 [1.23-1.91],0.0001684474033178
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,15700,238,1.01 [0.86-1.20],0.8720870268531329
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,18780,293,1.03 [0.82-1.28],0.8021826271832081
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,15700,238,1.05 [0.82-1.34],0.7110472816642609
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,15777,238,0.90 [0.57-1.43],0.660689923536067
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,15777,238,0.93 [0.65-1.34],0.7021769169344121
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,15700,238,0.88 [0.66-1.17],0.3695915968286026
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,15741,240,0.83 [0.62-1.12],0.2243858654363256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,18230,284,0.90 [0.77-1.06],0.2044133711219472
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,15689,238,1.10 [0.86-1.41],0.4536140648041485
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,16189,244,1.14 [0.74-1.76],0.5535032074727702
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,15741,240,1.10 [0.97-1.24],0.1561465172662998
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,18646,290,0.99 [0.82-1.20],0.9322455169934852
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCT,Secretin,15777,238,1.17 [0.91-1.50],0.2162969820447586
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,18653,291,1.02 [0.79-1.33],0.8698309538585954
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,18653,291,0.98 [0.79-1.23],0.8784322569335432
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,16130,242,1.02 [0.91-1.14],0.7477910241104582
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,16136,244,0.83 [0.67-1.04],0.1043390991173847
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,15830,235,0.89 [0.63-1.25],0.4951275049598331
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,15741,240,1.01 [0.86-1.18],0.9469987123995816
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,15741,240,1.02 [0.68-1.54],0.9139624816645764
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,18887,296,1.10 [0.90-1.35],0.3457665251509386
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,16213,244,1.25 [0.75-2.09],0.3949352099971611
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,16213,244,1.37 [0.78-2.38],0.2703782279501423
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,18745,294,0.97 [0.80-1.16],0.7134179208256364
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,18646,290,1.27 [0.84-1.91],0.2532428069850763
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,18653,291,1.32 [0.89-1.94],0.1658400917225465
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,15830,235,1.12 [0.85-1.47],0.4220466281399728
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,18561,288,0.90 [0.62-1.32],0.5979055188634065
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,18821,295,1.11 [0.79-1.56],0.5552419470821204
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,15703,236,1.11 [0.69-1.78],0.6546419213162675
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,18827,296,1.26 [0.87-1.83],0.2153187939924455
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,16168,245,0.97 [0.83-1.14],0.7175145207084459
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,15910,241,0.93 [0.73-1.19],0.5641050005641153
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,16129,245,0.95 [0.64-1.41],0.8057258141597315
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,18561,288,1.12 [0.79-1.60],0.5145416750861234
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,15918,242,2.70 [0.80-9.08],0.108688208931645
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,18887,296,1.07 [0.84-1.38],0.5704782532758748
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,18133,286,0.99 [0.89-1.11],0.926407553040932
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,16170,244,1.11 [0.50-2.47],0.7962494923209457
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,15924,243,0.96 [0.57-1.62],0.8816447684086544
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,15977,243,1.15 [0.78-1.70],0.4875023747263154
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,16213,244,2.28 [1.05-4.95],0.0373588095834535
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,16213,244,0.72 [0.37-1.41],0.3411455975967546
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,18483,288,0.97 [0.84-1.13],0.7131779933227504
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,18597,290,0.99 [0.88-1.11],0.8713862812072419
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,18323,284,0.92 [0.74-1.15],0.479691296035032
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,18758,294,1.11 [0.93-1.32],0.2508168013443935
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,18876,294,0.93 [0.78-1.12],0.4526825026853623
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,18504,291,0.88 [0.64-1.20],0.4140684648444968
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,16188,244,1.39 [0.61-3.20],0.4354121030357317
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,16188,244,1.57 [1.02-2.42],0.0397224870310211
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,18887,296,0.98 [0.84-1.15],0.8430831688427936
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,16189,244,1.04 [0.86-1.25],0.7189546792085764
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,15976,243,1.18 [0.74-1.86],0.4860487454914851
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,15908,242,2.00 [0.81-4.97],0.1348410476781119
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,16188,244,1.16 [0.60-2.25],0.6631006680460241
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,15910,241,1.01 [0.91-1.11],0.9006941477821031
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,15803,235,0.73 [0.46-1.15],0.1777518029035788
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,16136,244,1.20 [0.97-1.48],0.0890629038967665
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,18258,289,0.88 [0.74-1.04],0.1360581905154449
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,18437,291,0.66 [0.47-0.92],0.013959867472093
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,15777,238,1.04 [0.69-1.57],0.854216467662799
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,18698,293,1.17 [0.81-1.70],0.3971167370287115
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,18561,288,0.97 [0.62-1.51],0.8813297803546699
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,18561,288,0.99 [0.85-1.14],0.8504044770399206
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,18436,290,1.00 [0.78-1.28],0.9939966718476614
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,15830,235,1.00 [0.73-1.38],0.9767547889939338
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,18230,284,1.07 [0.90-1.28],0.4360475325412917
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,18230,284,1.02 [0.84-1.24],0.84532902760608
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,18653,291,1.20 [1.03-1.40],0.0178050428000783
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,15938,241,1.15 [0.93-1.43],0.1966629871331709
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,18230,284,1.03 [0.92-1.14],0.6370629065590463
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,18646,290,0.88 [0.72-1.07],0.1898977053853907
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,15700,238,1.00 [0.82-1.23],0.9621671281858172
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,16136,244,1.02 [0.80-1.30],0.8597452530674814
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,15814,240,1.00 [0.86-1.16],0.9825290418001958
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,16161,245,0.91 [0.76-1.09],0.322969114039645
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,16208,243,0.87 [0.67-1.14],0.3116386492290872
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,15627,234,0.92 [0.81-1.03],0.1467703285950797
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,15633,237,1.01 [0.87-1.17],0.9122645449918614
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,15703,236,1.16 [0.88-1.53],0.3031509641417541
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,16200,246,0.99 [0.61-1.61],0.970140503703417
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",18689,288,0.94 [0.83-1.06],0.3075980094963608
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,15910,241,0.93 [0.68-1.28],0.6667951471609938
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,18669,293,0.96 [0.76-1.21],0.7288382291298163
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,18710,288,1.17 [0.91-1.51],0.2180685651411624
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,18646,290,0.89 [0.65-1.23],0.4920652159899993
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,18258,289,1.02 [0.88-1.17],0.8182678451169381
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,18654,292,1.00 [0.92-1.10],0.941527637011725
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,18830,294,1.15 [0.84-1.57],0.3945254847243911
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,18653,291,1.44 [1.01-2.07],0.0450750340961034
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,15741,240,1.26 [0.96-1.66],0.1014413532959719
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,18804,294,1.38 [0.97-1.96],0.0699001827175622
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,15741,240,0.97 [0.66-1.43],0.8792397630106763
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,18706,296,1.03 [0.86-1.24],0.710415046836719
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,18584,286,1.14 [0.91-1.42],0.2536529114917526
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,15703,236,0.98 [0.84-1.15],0.7989118491930135
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,18561,288,0.97 [0.86-1.09],0.6152287197759284
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",18258,289,1.18 [0.99-1.40],0.0600309860368213
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,18340,284,1.18 [0.98-1.42],0.0873960228072167
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,18476,291,0.99 [0.86-1.14],0.8845910370023449
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,18710,288,0.99 [0.90-1.09],0.8362983510707817
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,15662,238,1.09 [0.80-1.49],0.5689875286114121
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,16168,245,0.99 [0.88-1.11],0.8351721297078447
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,18340,284,1.07 [0.90-1.28],0.451850914789163
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,18230,284,1.02 [0.77-1.36],0.8837692294223887
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,18646,290,0.98 [0.82-1.17],0.7882337477247213
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,18230,284,0.92 [0.76-1.13],0.4369866190148336
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,15662,238,0.99 [0.63-1.56],0.962459734733613
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,16130,242,0.95 [0.76-1.18],0.6213161179034061
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,18258,289,0.95 [0.78-1.15],0.591578024406064
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,15777,238,0.94 [0.73-1.22],0.6571475888748227
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,18258,289,1.02 [0.87-1.19],0.8335088119822645
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,15627,234,0.82 [0.64-1.04],0.1036186136062233
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,15627,234,1.04 [0.80-1.35],0.7690667200877208
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,18258,289,1.02 [0.75-1.39],0.8859585556635677
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,18646,290,1.01 [0.83-1.25],0.8903778947902032
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,15777,238,1.00 [0.83-1.20],0.9596988012031816
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,16200,246,0.73 [0.56-0.95],0.0182764399623748
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,15662,238,1.08 [0.91-1.27],0.3874903832893978
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,15830,235,0.99 [0.85-1.14],0.8479217417765132
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,16136,244,1.03 [0.81-1.31],0.7878013883181173
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",15627,234,0.85 [0.66-1.09],0.1981209799087523
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,18258,289,0.85 [0.69-1.05],0.1262863254242429
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,15703,236,0.82 [0.55-1.20],0.3035312028532834
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,18830,294,0.96 [0.74-1.24],0.735365004080976
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,18323,284,0.97 [0.72-1.32],0.8642385442259886
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,15910,241,0.95 [0.80-1.13],0.5539385827474457
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,16136,244,1.02 [0.88-1.19],0.7608978064972499
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,16084,243,1.09 [0.78-1.52],0.6104937734055476
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,18230,284,1.01 [0.89-1.14],0.9037719376084604
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,16130,242,1.02 [0.85-1.22],0.8331962617654411
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,16130,242,1.04 [0.82-1.31],0.7735516708833697
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,18561,288,1.20 [0.70-2.07],0.5122139147259172
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,18258,289,1.02 [0.88-1.18],0.7789524194796253
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,15627,234,1.01 [0.80-1.28],0.9366657996212524
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,16136,244,1.00 [0.82-1.22],0.9870751205488036
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,18830,294,1.18 [0.86-1.61],0.3005358230986582
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,18710,288,1.07 [0.82-1.40],0.6205281511286992
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,18726,293,0.93 [0.76-1.14],0.5023438512503742
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,15703,236,1.00 [0.79-1.26],0.9882110790670144
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,18674,286,0.97 [0.83-1.14],0.7349135206036523
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,16130,242,0.96 [0.81-1.14],0.6267731666296221
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,15700,238,0.97 [0.80-1.19],0.8037985712384627
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,16128,244,1.01 [0.88-1.16],0.9220352363987055
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,18653,291,1.01 [0.90-1.14],0.8638870689331424
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,15700,238,1.00 [0.77-1.30],0.9936450907603536
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,18698,293,0.98 [0.88-1.10],0.7628024844419113
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,16168,245,0.96 [0.78-1.19],0.7324499628053548
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,15830,235,0.94 [0.84-1.05],0.2573489198490544
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,18504,291,0.99 [0.85-1.16],0.8967739564744956
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",15741,240,0.88 [0.58-1.31],0.5181517272253362
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',16161,245,1.03 [0.80-1.33],0.8225555324987988
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,15662,238,1.03 [0.85-1.25],0.776220511908742
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,15830,235,0.92 [0.72-1.16],0.4671219068385989
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,16136,244,1.02 [0.77-1.34],0.908752272892533
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,16130,242,1.06 [0.92-1.22],0.3983837575349215
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,15741,240,0.93 [0.60-1.43],0.7345969877401277
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,18653,291,1.01 [0.86-1.18],0.9408818843328676
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],18304,282,0.81 [0.64-1.02],0.0698041295693218
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",18654,292,0.96 [0.72-1.27],0.7594381777939752
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,16208,243,0.98 [0.80-1.20],0.850979410622869
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,16168,245,1.07 [0.80-1.43],0.6612078033685664
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,18230,284,1.10 [0.81-1.49],0.5426399495989216
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,18745,291,0.94 [0.81-1.09],0.3979496655491462
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,18633,291,1.06 [0.80-1.39],0.6982067271571315
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,18633,291,0.95 [0.73-1.24],0.7163824806811271
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,15777,238,0.90 [0.68-1.18],0.4431231218128656
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,16130,245,0.88 [0.52-1.48],0.6217659071461475
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,15777,238,1.14 [0.72-1.82],0.5763797137898545
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,16168,245,0.78 [0.51-1.21],0.2737472852242407
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,16168,245,0.92 [0.74-1.15],0.4553702954869435
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,18698,293,0.99 [0.85-1.14],0.8597447875540332
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,18680,293,0.93 [0.64-1.36],0.7145192004920926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPART,Spartin,15830,235,0.99 [0.83-1.16],0.8669036297533991
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,16189,244,1.20 [0.85-1.70],0.2974434706660949
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,18654,292,1.26 [0.99-1.60],0.0613984892792431
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,15830,235,1.04 [0.72-1.49],0.8353121902916427
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,18646,290,1.05 [0.89-1.22],0.5706188979212418
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,18654,292,1.00 [0.75-1.35],0.9914381393608748
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,18830,294,1.11 [0.91-1.35],0.3148152222608518
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,15662,238,0.83 [0.56-1.22],0.3359041489866438
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,18586,290,1.09 [0.72-1.65],0.6820448693100434
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,18710,288,1.03 [0.79-1.35],0.8069621033080348
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,16136,244,0.99 [0.92-1.07],0.8225038678700001
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,18504,291,0.82 [0.55-1.22],0.3320634294344985
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,18650,288,1.29 [0.94-1.76],0.1199010109377021
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,18572,291,1.04 [0.77-1.42],0.779853406032373
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,18857,296,1.17 [0.92-1.48],0.1941146695164919
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",15703,236,1.17 [0.88-1.56],0.2789200401459155
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,15627,234,1.02 [0.83-1.25],0.8580097816453371
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,15910,241,0.93 [0.79-1.09],0.3497144207492433
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,16161,245,0.86 [0.70-1.04],0.1252968960847702
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,18340,284,1.04 [0.93-1.17],0.458193372605496
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",15700,238,0.74 [0.49-1.13],0.1647456937143495
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,16161,245,1.02 [0.75-1.40],0.8913616731455054
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,18669,293,1.02 [0.93-1.11],0.6801024783930161
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,18561,288,0.95 [0.80-1.13],0.5763779023166449
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,18646,290,1.03 [0.91-1.16],0.6847919384924982
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,16189,244,0.91 [0.67-1.24],0.5588743521162729
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,18258,289,0.94 [0.78-1.13],0.5040090822633729
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",15703,236,1.25 [0.91-1.71],0.1635495973456308
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,18633,291,1.03 [0.95-1.12],0.4510647729713714
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,18745,294,1.07 [0.84-1.37],0.5576201166548509
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,15627,234,0.90 [0.58-1.41],0.6544915498921684
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,16136,244,1.10 [0.87-1.39],0.4368327827565507
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,15830,235,0.84 [0.67-1.06],0.1510975632834993
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",18561,288,1.06 [0.83-1.35],0.6293021321951358
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",18887,296,1.18 [0.85-1.62],0.3263955535875702
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",15703,236,0.85 [0.64-1.14],0.2698732681340399
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,16200,246,1.40 [0.91-2.18],0.1284955390780174
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,16130,242,0.78 [0.54-1.12],0.1796310696123774
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,18476,291,1.00 [0.84-1.18],0.9649610063274676
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,15703,236,1.10 [0.94-1.30],0.2416420363091641
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,18561,288,1.00 [0.93-1.08],0.9939250127366908
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,15627,234,0.93 [0.76-1.14],0.5078351028664327
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,18821,295,1.13 [0.90-1.41],0.2996823682772673
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,18632,292,1.21 [0.78-1.88],0.3989009652628346
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,15700,238,0.98 [0.82-1.17],0.8524956154181094
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,18617,290,0.94 [0.80-1.11],0.4710544389284692
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,18323,284,0.93 [0.80-1.08],0.3265678308964538
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,18258,289,1.02 [0.86-1.21],0.8359122077851083
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,18653,291,1.03 [0.91-1.16],0.6526566006582344
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",15627,234,1.02 [0.89-1.16],0.8077587665223875
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,18230,284,0.91 [0.75-1.11],0.3599266801703012
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,15777,238,0.95 [0.69-1.31],0.762583316203062
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,16161,245,0.94 [0.67-1.30],0.701861337229891
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,18561,288,1.03 [0.86-1.23],0.7397968386651708
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,15703,236,1.22 [0.92-1.60],0.1620691091987433
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,18230,284,0.96 [0.81-1.14],0.6581283874549355
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,15703,236,0.76 [0.58-0.98],0.0359449086202184
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,18646,290,1.03 [0.83-1.28],0.7817333698351926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,16168,245,0.96 [0.82-1.12],0.6271224671997759
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,18230,284,0.89 [0.69-1.14],0.3606103744023253
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,16136,244,1.06 [0.78-1.44],0.6952951889374829
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,18230,284,0.98 [0.86-1.12],0.7636273797828245
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,18821,295,1.00 [0.93-1.09],0.954068095188839
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,18646,290,1.03 [0.86-1.24],0.7154236159376626
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,15703,236,1.10 [0.92-1.31],0.3080882440453483
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,18821,295,1.04 [0.85-1.27],0.715946137983007
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",16168,245,1.05 [0.87-1.28],0.5990789720132708
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,18323,284,0.89 [0.72-1.10],0.2711527869081614
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,18654,292,1.09 [0.76-1.57],0.6284381095635869
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,16130,242,1.11 [0.82-1.49],0.5090261030322915
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,15759,235,0.79 [0.54-1.14],0.2001037568808278
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,15777,238,0.94 [0.76-1.16],0.547547598411628
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,16136,244,1.16 [0.85-1.59],0.3528615878762478
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,15830,235,0.97 [0.77-1.21],0.7627253554217851
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,15700,238,0.92 [0.73-1.16],0.4710935333199514
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,16161,245,1.02 [0.76-1.37],0.8710603320083847
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,16189,244,0.99 [0.84-1.17],0.912319063339892
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,15910,241,1.01 [0.89-1.13],0.9315359629349638
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,18561,288,0.99 [0.91-1.08],0.8668557139602815
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,16531,257,1.76 [1.20-2.59],0.003991206647178
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,16130,242,0.94 [0.69-1.28],0.7006462330557648
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,18561,288,0.99 [0.75-1.32],0.961881513312116
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,15627,234,0.89 [0.72-1.11],0.302721810417022
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,16151,245,0.97 [0.73-1.28],0.8073458244823244
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,18340,284,1.09 [0.94-1.26],0.2572089500566326
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,15910,241,0.99 [0.80-1.23],0.9291521571052906
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,18258,289,1.00 [0.88-1.15],0.9878183519647455
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",15777,238,1.00 [0.85-1.19],0.9554774660371868
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",16130,242,0.92 [0.67-1.28],0.6260966919791783
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,16161,245,1.07 [0.88-1.31],0.4777110110322278
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,18258,289,0.91 [0.71-1.16],0.4445255143756113
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,18561,288,1.00 [0.89-1.12],0.9384269801782053
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,18646,290,0.99 [0.86-1.13],0.8732650311195888
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,15830,235,0.93 [0.80-1.09],0.3933868286223521
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,18504,291,0.97 [0.87-1.07],0.524736519089614
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,18504,291,0.97 [0.85-1.10],0.6157695589887495
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,18230,284,1.04 [0.92-1.18],0.5261333096299114
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,15777,238,0.99 [0.76-1.28],0.9206146457974244
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,18481,291,0.98 [0.89-1.09],0.7701452751891655
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,18323,284,1.00 [0.87-1.14],0.9549625051654548
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,15887,237,1.02 [0.71-1.47],0.9030050609043174
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,18857,296,0.99 [0.71-1.38],0.9432107216653718
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,16189,244,1.39 [0.98-1.97],0.0617515905228769
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,15910,241,0.94 [0.74-1.18],0.581925524335654
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,16189,244,1.63 [1.10-2.42],0.0160211620844663
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,18258,289,1.04 [0.97-1.12],0.2410707460860475
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",15777,238,0.87 [0.61-1.24],0.4469837943923705
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,16130,242,0.99 [0.83-1.18],0.919533665645701
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,18258,289,1.00 [0.89-1.14],0.9473998564796954
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,15662,238,1.33 [1.04-1.70],0.0210015754511366
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,18698,293,1.17 [0.73-1.86],0.5124460813247823
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,15703,236,1.26 [0.83-1.92],0.2825884900516165
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,15881,241,0.90 [0.78-1.03],0.1287736429563654
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,15777,238,0.95 [0.78-1.17],0.6378271076440345
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,15910,241,0.94 [0.66-1.32],0.7021448843399436
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,16213,244,0.85 [0.48-1.49],0.5641076458103682
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,15700,238,0.91 [0.74-1.13],0.4030689447367894
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,18577,291,1.03 [0.90-1.16],0.7022420781873733
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,18689,288,1.10 [0.92-1.31],0.2891831635527189
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,18662,293,1.09 [0.82-1.43],0.562089864175801
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,18631,293,0.93 [0.66-1.31],0.6816571422109929
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,18644,293,1.22 [0.98-1.52],0.0773817526532878
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,18745,293,0.96 [0.73-1.27],0.7967994857404184
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,16130,242,0.99 [0.88-1.12],0.886125727251703
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,18646,290,1.14 [0.91-1.43],0.2423578933548428
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,18842,293,0.97 [0.74-1.27],0.8073474864311276
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,16130,242,1.10 [0.88-1.37],0.3917416336587667
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,18571,290,1.06 [0.72-1.57],0.7510337266599674
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,15703,236,1.29 [0.76-2.18],0.3490267366363667
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,18698,293,1.06 [0.78-1.45],0.6906346184227635
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,18887,296,0.93 [0.66-1.31],0.6798799004630536
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,18621,291,0.94 [0.82-1.07],0.3415698368828401
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,16208,243,0.92 [0.58-1.47],0.7342849807394134
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,15600,234,1.12 [0.98-1.28],0.0843254799876232
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,18653,291,1.22 [0.86-1.72],0.2577126638293318
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,18654,292,1.06 [0.80-1.39],0.6892551363487968
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,18690,293,1.04 [0.83-1.31],0.7091610405808031
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,18569,290,0.84 [0.60-1.19],0.3247776388373057
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,18323,284,0.98 [0.75-1.29],0.908069233648956
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,15662,238,1.00 [0.89-1.13],0.9348399566516102
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,15584,235,1.06 [0.73-1.53],0.774860763661823
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,16091,242,0.97 [0.84-1.12],0.713418670517523
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,18821,295,1.18 [0.83-1.68],0.3481056384990748
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,18118,282,1.00 [0.91-1.09],0.9461280843995096
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,18887,296,0.96 [0.76-1.22],0.7435760733338227
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",18230,289,0.99 [0.78-1.24],0.9003659309513574
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,15910,241,0.74 [0.51-1.07],0.1067474814636942
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,18745,294,1.08 [0.84-1.37],0.5524622197554955
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,16189,244,1.11 [0.82-1.50],0.4936438456361672
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,16161,245,1.02 [0.88-1.18],0.7790287416456482
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,18485,290,1.11 [0.77-1.60],0.5796146906481807
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,16189,244,0.76 [0.45-1.30],0.3187622738790808
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,18710,288,1.01 [0.93-1.10],0.7945790026531605
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,18654,292,0.77 [0.59-1.01],0.0612969406506741
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,18604,291,1.53 [0.96-2.45],0.0764681380175045
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,18698,293,1.01 [0.89-1.15],0.8331841257006903
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,15700,238,0.80 [0.57-1.10],0.1713040132068287
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",15910,241,1.04 [0.80-1.37],0.7578662569323066
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,15703,236,1.23 [0.77-1.97],0.3926331945927153
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,15910,241,0.91 [0.53-1.55],0.7186187089906719
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,18876,294,1.06 [0.89-1.25],0.5250071870057065
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,15703,236,1.36 [0.88-2.09],0.161870630436504
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,15777,238,0.96 [0.76-1.22],0.757368262623932
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,15910,241,0.99 [0.80-1.24],0.96357717271219
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,15662,238,0.77 [0.53-1.10],0.1517852373527958
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,15662,238,1.11 [0.91-1.36],0.2968713227181994
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,16136,244,0.99 [0.88-1.11],0.8436286937699784
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,16130,242,0.93 [0.78-1.11],0.4101419991595159
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,15741,240,0.97 [0.79-1.18],0.7455675131541423
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,16168,245,0.83 [0.62-1.11],0.2068665954467464
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,15627,234,0.96 [0.69-1.32],0.7841474295295011
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,15700,238,0.93 [0.78-1.11],0.4143867626065801
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,16129,245,1.31 [0.97-1.76],0.0766394167418173
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,18561,288,1.15 [1.02-1.29],0.0185716463232109
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,18416,291,1.16 [0.88-1.53],0.2881101589052701
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,18654,292,1.00 [0.87-1.16],0.9448147937234964
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,18745,294,0.99 [0.80-1.23],0.952551653633632
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,18298,284,1.04 [0.77-1.41],0.7963381262357525
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,16136,244,1.06 [0.82-1.36],0.6637642532802046
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,18340,284,1.05 [0.79-1.39],0.7536676018036985
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,15830,235,0.96 [0.78-1.18],0.7034480593099013
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,18504,291,0.79 [0.57-1.10],0.1652854784040505
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,18504,291,1.20 [1.01-1.43],0.0413139525967711
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,18698,293,0.96 [0.78-1.19],0.7107244524776961
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,18876,294,1.24 [0.96-1.60],0.1001915368424859
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,18620,288,1.12 [0.79-1.60],0.5215665789075701
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,18698,293,1.12 [0.84-1.50],0.4252646244695763
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,18650,288,1.09 [0.79-1.51],0.6016886536747993
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,18340,284,1.09 [0.84-1.41],0.5315483209268805
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,18650,288,1.10 [0.78-1.54],0.5914706597627596
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,15830,235,0.85 [0.63-1.16],0.3037051043388992
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,18830,294,1.03 [0.76-1.41],0.8351969292811545
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,18654,292,1.15 [0.83-1.61],0.4038038585017638
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,18654,292,1.16 [0.89-1.51],0.2745401523870026
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,18821,295,1.16 [0.80-1.68],0.4256227649468377
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,18842,293,1.12 [0.85-1.48],0.4041769652430673
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,18504,291,1.06 [0.88-1.27],0.5435433654683275
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,18821,295,1.09 [0.86-1.38],0.4617816056310847
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,18504,291,1.20 [0.93-1.55],0.1557422786723111
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,18876,294,1.21 [0.81-1.81],0.3478762217736123
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,18646,290,0.94 [0.79-1.12],0.4917476764770419
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,18876,294,0.99 [0.69-1.43],0.970808428765368
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,18710,288,1.06 [0.72-1.57],0.7633974279997771
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,18856,296,1.29 [0.89-1.87],0.1857246420597603
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,18504,291,0.95 [0.79-1.14],0.566902217777685
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,16200,246,1.24 [0.89-1.72],0.2016325823366188
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,16161,245,1.01 [0.88-1.16],0.8744764208593472
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,16200,246,0.97 [0.73-1.29],0.8333939324738189
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",18323,284,1.01 [0.89-1.14],0.9000093058626735
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,15910,241,0.87 [0.61-1.25],0.4548079385215225
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,18504,291,0.93 [0.73-1.19],0.5774188031299663
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,18654,292,0.71 [0.48-1.07],0.101376849540489
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,16189,244,0.98 [0.83-1.15],0.8006425969004857
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,16136,244,0.96 [0.87-1.06],0.4291208663941016
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",15627,234,1.02 [0.79-1.31],0.8948989656967677
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,15703,236,1.05 [0.90-1.23],0.5273017961522823
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,15741,240,0.99 [0.78-1.26],0.9560833918921424
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,18230,284,1.10 [0.86-1.40],0.4421281045207359
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,15703,236,0.91 [0.78-1.06],0.2177719918328194
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,15485,230,1.00 [0.78-1.29],0.9767767492527172
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,18323,284,1.38 [1.04-1.82],0.0261266627837809
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,15777,238,0.95 [0.66-1.38],0.7971911877804021
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,15777,238,0.84 [0.61-1.17],0.3079106549609877
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,15830,235,0.95 [0.85-1.06],0.3695487921077145
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,16189,244,0.89 [0.57-1.38],0.5948015992233605
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,15662,238,1.18 [0.92-1.52],0.1956090321904068
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,18230,284,0.94 [0.81-1.10],0.4466038861712578
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,18503,287,1.01 [0.80-1.26],0.95554319435511
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,15910,241,1.05 [0.91-1.22],0.4938150819428848
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,18258,289,1.06 [0.82-1.38],0.6417742302629449
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,15662,238,0.92 [0.70-1.20],0.522589335470423
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,15627,234,1.08 [0.91-1.28],0.4091411623865818
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,18850,294,1.10 [0.91-1.35],0.3289902063127468
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,16168,245,0.95 [0.67-1.33],0.7457748661654913
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,15703,236,1.52 [1.00-2.29],0.0473685118335353
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,18340,284,1.09 [0.95-1.26],0.21548671404604
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,18646,290,0.95 [0.82-1.11],0.5365330560730676
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",15703,236,1.09 [0.80-1.49],0.5841605781278024
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,15662,238,0.79 [0.58-1.07],0.1217961175516864
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,15910,241,0.92 [0.80-1.07],0.3046514284089925
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,16200,246,1.07 [0.90-1.26],0.4359390914025813
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,18620,288,1.18 [0.98-1.43],0.0887191480263002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,16208,243,1.08 [0.86-1.36],0.5229759615568149
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,18654,292,1.20 [0.89-1.62],0.2404171071581566
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,18830,294,0.99 [0.83-1.17],0.8853793302264956
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,18646,290,0.96 [0.83-1.11],0.5552023174032499
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,15883,241,1.05 [0.87-1.26],0.6427253543868008
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,16136,244,1.05 [0.93-1.17],0.4323608728274422
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,15627,234,1.06 [0.86-1.32],0.5743816588539112
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,15777,238,0.94 [0.79-1.12],0.5146939071167584
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,18646,290,1.06 [0.94-1.20],0.3539683815843747
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,16130,242,0.95 [0.82-1.10],0.4825490477720965
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,15662,238,1.06 [0.83-1.35],0.6623914825204795
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,15703,236,0.98 [0.82-1.17],0.8207581062155326
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,16168,245,1.05 [0.87-1.26],0.6383479726490358
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,18653,291,1.00 [0.87-1.16],0.9770715934867644
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,18323,284,0.98 [0.82-1.18],0.83694199892323
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,15662,238,1.00 [0.73-1.38],0.9838446945990648
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,18323,284,1.12 [1.01-1.25],0.0389803039604053
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,15662,238,0.88 [0.67-1.15],0.3405372636724094
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,15700,238,0.92 [0.80-1.06],0.2550129589057344
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,16136,244,1.12 [0.98-1.28],0.0861662142186808
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,15703,236,1.05 [0.76-1.45],0.7603323124153887
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,18228,288,0.95 [0.82-1.09],0.4445659432514813
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,15777,238,1.06 [0.82-1.37],0.6425015802928951
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TTN,Titin,15662,238,1.08 [0.90-1.28],0.4107556923286144
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,16050,244,0.89 [0.54-1.46],0.6451003745740993
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,15700,238,1.00 [0.65-1.55],0.9931093182199668
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,16200,246,0.98 [0.85-1.13],0.8010336047736848
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,15910,241,1.03 [0.89-1.21],0.6670568586901402
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,18504,291,1.03 [0.91-1.16],0.6754411513033844
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,15947,237,0.87 [0.64-1.18],0.3592559596174934
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,18698,293,0.92 [0.63-1.34],0.6477769627230969
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,18821,295,1.06 [0.92-1.24],0.4144740312579501
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,16161,245,1.06 [0.84-1.34],0.6114801231855223
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,15671,236,0.98 [0.86-1.12],0.7816658090975198
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",18654,292,0.97 [0.77-1.22],0.7738895615586238
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,18539,290,0.97 [0.83-1.14],0.7340344126821845
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,18653,291,0.96 [0.66-1.38],0.8063202163588549
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",15703,236,1.06 [0.86-1.29],0.592549919556633
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,18561,288,0.82 [0.60-1.13],0.2250573452400199
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,16130,242,0.92 [0.59-1.41],0.6936292257514719
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,16189,244,0.99 [0.81-1.22],0.9528034570184544
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,15703,236,1.01 [0.81-1.26],0.9631411150055073
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,15662,238,0.91 [0.72-1.15],0.4251956672407158
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,15830,235,0.96 [0.80-1.16],0.701344078817044
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,16136,244,0.99 [0.91-1.08],0.7885335352934404
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,15662,238,0.92 [0.80-1.06],0.2447506398477898
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,15662,238,1.03 [0.72-1.48],0.8598996914618865
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,18504,291,1.04 [0.79-1.36],0.7810181199032492
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,18822,295,1.06 [0.87-1.29],0.5771888305514021
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,15703,236,1.06 [0.65-1.71],0.8257439970786775
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,15627,234,1.11 [0.89-1.39],0.355202962812141
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,16130,242,0.95 [0.67-1.35],0.7698925669078118
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,16189,244,1.00 [0.87-1.14],0.9445641219257914
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,15700,238,0.92 [0.71-1.18],0.4990117150561346
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,15872,241,0.96 [0.75-1.23],0.7385530497315925
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,15830,235,0.94 [0.77-1.13],0.4901745967834113
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,15777,238,0.93 [0.77-1.13],0.4868475782557644
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,18561,288,0.97 [0.86-1.09],0.5938163836863756
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,16130,242,1.04 [0.87-1.23],0.6828859857358931
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,16161,245,1.36 [1.03-1.79],0.0303655530552279
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,15662,238,0.85 [0.73-1.01],0.0606988271162827
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,18323,284,0.98 [0.88-1.10],0.7853258379236225
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,18230,284,0.98 [0.79-1.20],0.8174148967553185
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,18323,284,0.81 [0.64-1.02],0.078740563479818
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,15703,236,1.00 [0.86-1.16],0.9978152752956584
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,18646,290,1.00 [0.88-1.13],0.9781798177698494
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,18380,286,1.03 [0.70-1.51],0.8899149733699492
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,16208,243,1.00 [0.84-1.19],0.9875182150670606
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,18561,288,0.62 [0.36-1.08],0.0899506002826868
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,15700,238,1.01 [0.89-1.14],0.9070159829491544
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,18722,293,0.98 [0.66-1.46],0.9346752531511372
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,18821,295,1.14 [0.81-1.61],0.4502049959378489
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,15627,234,1.01 [0.88-1.17],0.856949061118876
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,18821,294,0.99 [0.82-1.19],0.8981588264104606
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,15703,236,0.83 [0.54-1.29],0.4144540618287546
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,18698,293,0.90 [0.75-1.08],0.246528950188838
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,18849,294,1.13 [0.86-1.49],0.3610563362933254
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,16168,245,0.94 [0.63-1.40],0.7637009259791235
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,18323,284,0.94 [0.86-1.02],0.116444629888174
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,15741,240,0.82 [0.47-1.43],0.4886952534864447
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,16189,244,1.18 [0.86-1.63],0.3119088299018255
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,18561,288,1.24 [1.06-1.46],0.0087278400188891
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,16208,243,0.97 [0.82-1.14],0.6993184207579755
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,18561,288,0.87 [0.70-1.08],0.2153377212789674
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,15910,241,0.93 [0.77-1.13],0.4852956254059577
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,18561,288,1.06 [0.93-1.20],0.400577307081872
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,16130,242,0.96 [0.84-1.10],0.568936352448541
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,18561,288,1.05 [0.92-1.20],0.4839516676554994
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,16130,242,0.96 [0.66-1.39],0.8283568748244303
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,15662,238,0.83 [0.56-1.23],0.3569489863024581
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,16130,242,1.18 [0.99-1.40],0.0669146540940285
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,18632,292,1.05 [0.82-1.33],0.7088582852732956
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,18623,290,1.04 [0.88-1.22],0.679385940927416
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,16161,245,0.94 [0.68-1.31],0.7340470229072682
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,18258,289,1.04 [0.85-1.27],0.719210004107242
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,15910,241,0.92 [0.67-1.27],0.6182787946506334
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,18323,284,0.88 [0.73-1.07],0.1914391249171972
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,18821,295,0.98 [0.85-1.14],0.8310861502739455
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,18230,284,1.04 [0.74-1.48],0.8132071381575648
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,15830,235,0.90 [0.71-1.13],0.3658808164555076
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,18806,293,1.00 [0.78-1.27],0.969638401611238
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,15627,234,0.93 [0.78-1.11],0.4012324853259957
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,18442,291,1.00 [0.78-1.30],0.9769586402815468
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,16168,245,0.89 [0.67-1.19],0.4406844708532932
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,18887,296,1.10 [0.96-1.26],0.1782549184802213
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",18654,292,0.91 [0.69-1.20],0.5161936283768578
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,18340,284,0.95 [0.80-1.12],0.5391513661838525
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,18323,284,0.98 [0.88-1.10],0.748862139838859
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,18258,289,1.02 [0.90-1.16],0.7191795589395676
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,16161,245,1.03 [0.88-1.21],0.7162600190997372
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,15703,236,1.00 [0.81-1.24],0.979457589808303
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,16130,242,0.95 [0.67-1.36],0.7863802927730517
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,15792,239,0.96 [0.76-1.22],0.7544447470497642
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,18794,293,0.89 [0.76-1.06],0.1896278874968586
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,17710,276,1.22 [0.94-1.57],0.1298138157339406
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",18437,291,1.16 [0.90-1.48],0.2566010988114278
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",18650,288,1.05 [0.77-1.44],0.7536452639500189
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,18830,294,0.80 [0.59-1.08],0.1423088909984499
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,18340,284,0.80 [0.55-1.15],0.2290107432237985
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,18504,291,1.00 [0.82-1.21],0.9680516032558076
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,18830,294,1.02 [0.84-1.24],0.836894629549957
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,18799,296,0.94 [0.70-1.26],0.6874035988827405
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,15703,236,1.06 [0.85-1.32],0.5854513502510218
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,18698,293,1.05 [0.95-1.16],0.3224963767615672
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,18258,289,1.00 [0.76-1.32],0.9989255158352052
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,16161,245,0.85 [0.53-1.35],0.4873110941982387
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",16136,244,0.97 [0.89-1.06],0.5010531451807689
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,18561,288,1.05 [0.95-1.15],0.3394258542512788
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,16130,242,1.07 [0.73-1.57],0.7272431916861978
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,15662,238,0.89 [0.72-1.09],0.2513017952453287
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,18340,284,0.97 [0.85-1.09],0.5938926190781091
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,15830,235,1.00 [0.84-1.19],0.9854557342081224
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,15703,236,1.31 [0.85-2.04],0.2218178358575631
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,15703,236,0.99 [0.71-1.39],0.9653493745822568
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,18230,284,1.04 [0.90-1.20],0.603209517857002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,18323,284,0.82 [0.62-1.09],0.1731929830555746
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,15662,238,0.80 [0.63-1.02],0.0711882517999698
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,16136,244,0.93 [0.81-1.07],0.3300899384947326
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,16161,245,1.04 [0.72-1.48],0.8460417795590052
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,15703,236,1.07 [0.77-1.48],0.6732703393609464
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,15910,241,1.01 [0.82-1.24],0.9267024123675252
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,16130,242,0.88 [0.74-1.05],0.1637908588889059
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,16136,244,1.04 [0.87-1.24],0.6505154191920186
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,16130,242,0.82 [0.65-1.05],0.11523105830314
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,15741,240,0.96 [0.92-1.01],0.082464135149959
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,15627,234,0.97 [0.65-1.45],0.8939690009626505
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,15700,238,0.93 [0.81-1.07],0.3155834168160628
